Other peripheral vertigo

H8_PERIPHVERTIGO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H81.3 Cause of death: ICD-10 — H81.3 2 out of 7 registries used, show all original rules.	3750
4. Check minimum number of events None	3750
5. Include endpoints None	3750
6. Filter based on genotype QC (FinnGen only)	3639

Control definitions (FinnGen only)

Control exclude: H8_INNER

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H81
Name in latin: Alia vertigo peripherica

NAME	H8_PERIPHVERTIGO
CONTROL_EXCLUDE	H8_INNER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H813
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H813
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other peripheral vertigo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22431	14326	8009
Only index persons	21331	13746	7585
Unadjusted period prevalence (%)
Whole population	0.34	0.41	0.22
Only index persons	0.43	0.51	0.29
Median age at first event (years)
Whole population	59.92	60.67	58.74
Only index persons	59.30	59.97	58.08

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3639	2365	1274
Unadjusted period prevalence (%)	0.75	0.84	0.58
Median age at first event (years)	58.81	57.48	61.30

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3750: Matched controls
37500

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H81.3

ICD-10 Finland

Other peripheral vertigo

4503599627370496.0

307.7

3749

125

R42

ICD-10 Finland

Dizziness and giddiness

11.4

307.7

2436

5257

H81.0

ICD-10 Finland

Ménière disease

98.4

307.7

481

H81.2

ICD-10 Finland

Vestibular neuronitis

251.4

307.7

404

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

12.6

307.7

1076

1161

N07CA01

ATC

betahistine; oral

12.2

307.7

1059

1169

DFF59

NOMESCO Finland

Other assessment of balance

37.3

307.7

251

Z01.1

ICD-10 Finland

Examination of ears and hearing

3.6

226.2

934

3159

N17

ICPC

Vertigo/dizziness

3.7

214.7

830

2680

DFF00

NOMESCO Finland

Pure tone audiometry

4.0

212.3

708

2065

DFF50

NOMESCO Finland

Electronystagmography

83.8

184.9

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

6.0

182.2

339

609

AA1AD

NOMESCO Finland

CT of head and brain

2.7

181.5

1468

7156

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

20.5

166.2

127

H81.4

ICD-10 Finland

Vertigo of central origin

24.8

149.9

106

DFF40

NOMESCO Finland

Otoneurologic examination of vertigo

34.5

127.8

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

10.1

124.3

142

145

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

5.7

99.9

192

353

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.4

99.3

871

4219

UDC00

NOMESCO Finland

Ear microscopy

3.2

92.6

408

1388

DC1AD

NOMESCO Finland

Temporalbone CT

9.7

87.7

103

109

R51.80

ICD-10 Finland

Headache

2.4

87.7

711

3308

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

79.7

1493

9526

G44.2

ICD-10 Finland

Tension-type headache

2.4

79.4

641

2966

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.8

77.3

439

1714

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

8.5

77.3

100

120

H82

ICPC

Vertiginous syndrome

5.7

73.0

137

246

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

71.3

1218

7475

R11

ICD-10 Finland

Nausea and vomiting

2.7

70.2

431

1747

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

62.2

389

1587

N05AB04

ATC

prochlorperazine; systemic, rectal

4.6

61.8

149

333

H93.1

ICD-10 Finland

Tinnitus

2.8

60.8

335

1282

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

57.6

410

1777

A02BC02

ATC

pantoprazole; systemic

1.8

55.0

2651

21531

L01

ICPC

Neck symptom/complaint

2.0

52.3

652

3539

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

51.2

1821

13500

A02BC05

ATC

esomeprazole; systemic

1.7

50.9

1605

11524

M79.6

ICD-10 Finland

Pain in limb

1.7

50.8

1620

11664

M54.5

ICD-10 Finland

Low back pain

1.7

49.8

1374

9502

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

48.3

913

5663

M03BX02

ATC

tizanidine; oral

1.7

47.8

2284

18135

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

47.3

868

5332

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

46.6

365

1646

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

46.0

717

4183

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

45.8

899

5627

R53

ICD-10 Finland

Malaise and fatigue

1.8

45.0

934

5938

R07.3

ICD-10 Finland

Other chest pain

2.1

42.6

438

2205

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

42.5

1162

7943

H02AB06

ATC

prednisolone; systemic

1.6

42.5

1815

13849

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

41.2

305

1340

DFF15

NOMESCO Finland

Speech audiometry

2.7

41.0

239

938

R06.0

ICD-10 Finland

Dyspnoea

1.7

39.5

1065

7227

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

39.4

279

1201

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

38.2

683

4133

N02BE01

ATC

paracetamol; systemic, rectal

2.0

38.0

3349

30230

H80.9

ICD-10 Finland

Otosclerosis, unspecified

197.0

37.9

K30

ICD-10 Finland

Functional dyspepsia

2.0

37.8

463

2480

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

37.7

623

3681

R01AD09

ATC

mometasone; nasal

1.6

37.6

1625

12310

R01AD08

ATC

fluticasone; nasal

1.6

37.0

1044

7147

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

36.9

259

1110

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.4

36.7

136

413

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.5

36.5

242

1010

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

36.3

1035

7097

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

36.1

664

4044

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

35.9

422

2225

M54.2

ICD-10 Finland

Cervicalgia

2.2

35.6

329

1585

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

35.2

700

4359

N03AX16

ATC

[U] pregabalin

1.6

34.4

904

6058

G47.3

ICD-10 Finland

Sleep apnoea

1.7

34.4

799

5186

J01DB01

ATC

cefalexin; oral

1.7

34.1

3015

26584

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

34.1

221

912

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

340.2

34.0

R55

ICD-10 Finland

Syncope and collapse

1.9

33.6

439

2398

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

33.6

518

2987

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

33.5

1029

7160

M79.1

ICD-10 Finland

Myalgia

1.8

33.4

545

3198

R00.2

ICD-10 Finland

Palpitations

2.2

33.3

314

1524

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

33.1

340

1705

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

32.9

811

5341

R12

ICD-10 Finland

Heartburn

2.1

32.8

316

1545

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

32.7

1561

11973

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.5

32.5

220

926

N01

ICPC

Headache

2.0

32.1

366

1905

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

32.0

406

2194

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

31.7

935

6429

J01AA02

ATC

doxycycline; systemic

1.6

31.2

2876

25234

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

31.1

626

3899

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

30.6

552

3332

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

30.5

880

6010

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

29.9

474

2752

M01AB05

ATC

diclofenac; systemic, rectal

1.5

29.8

2372

20040

XF404

NOMESCO Finland

Ambulatory ECG

2.0

29.6

357

1895

M25.5

ICD-10 Finland

Pain in joint

1.5

29.4

1142

8333

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

29.4

1817

14582

M01AH05

ATC

etoricoxib; oral

1.5

29.3

2191

18249

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

29.0

825

5606

L17

ICPC

Foot/toe symptom/complaint

1.5

28.8

1056

7603

A02BC03

ATC

lansoprazole; oral

1.5

28.6

1078

7804

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

28.6

1601

12574

H02

ICPC

Hearing complaint

1.7

28.5

542

3316

Z01.2

ICD-10 Finland

Dental examination

1.5

28.5

1540

12011

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

4.6

28.5

147

PA6AD

NOMESCO Finland

CT of neck arteries

2.9

28.3

132

460

J01FA09

ATC

clarithromycin; systemic

1.5

28.3

1100

8017

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

28.0

262

1265

N02AX02

ATC

tramadol; systemic, rectal

1.5

28.0

1553

12160

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

28.0

417

2372

J01FA10

ATC

azithromycin; systemic

1.5

27.9

1970

16155

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

27.9

392

2188

R01AD58

ATC

fluticasone, combinations; nasal

1.6

27.9

805

5484

UJF32

NOMESCO Finland

Coloscopy

1.5

27.8

992

7090

DDA00

NOMESCO Finland

Stapedotomy

78.2

27.8

A02BA02

ATC

ranitidine; systemic

1.6

27.6

738

4935

R51

ICD-10 Finland

Headache

2.3

27.5

206

907

R03AC02

ATC

salbutamol; inhalant

1.5

27.3

1939

15893

N06AX11

ATC

mirtazapine; oral

1.5

27.1

1224

9187

A11

ICPC

Chest pain NOS

2.0

26.8

333

1784

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.1

26.7

273

1365

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

26.3

1075

7894

J01MA02

ATC

ciprofloxacin; systemic

1.5

26.1

1387

10730

L08

ICPC

Shoulder symptom/complaint

1.6

26.0

806

5569

M01AE02

ATC

naproxen; oral, rectal

1.4

26.0

1971

16291

UKC02

NOMESCO Finland

Cystoscopy

1.7

26.0

578

3684

L03

ICPC

Low back symptom/complaint

1.5

25.8

984

7115

H92.0

ICD-10 Finland

Otalgia

2.2

25.8

225

1057

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

25.7

391

2235

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

25.3

1883

15477

H83.1

ICD-10 Finland

Labyrinthine fistula

+∞

25.0

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

25.0

677

4528

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.7

24.8

133

500

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

24.7

310

1665

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

24.6

298

1581

H02AB04

ATC

methylprednisolone; systemic

1.7

24.3

532

3373

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

24.1

175

760

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

24.0

448

2718

N03AX12

ATC

[U] gabapentin; oral

1.6

24.0

610

4013

R05

ICPC

Cough

1.5

24.0

854

6070

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

23.9

508

3193

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.7

23.9

135

521

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

23.9

1465

11584

SPAT1097

SPAT

Recording of ECG

1.6

23.8

558

3598

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

23.8

425

2548

S06.0

ICD-10 Finland

Concussion

1.8

23.7

373

2153

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

23.6

1422

11204

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

23.3

1317

10245

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

23.2

2436

21146

XF402

NOMESCO Finland

ECG with work load test

1.8

23.0

408

2440

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

3.4

23.0

239

C07AA05

ATC

propranolol; systemic

1.6

22.9

697

4780

DAX08

NOMESCO Finland

Fitting of hearing aid

2.1

22.9

220

1073

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

22.9

654

4421

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.2

22.8

195

908

R52.9

ICD-10 Finland

Pain, unspecified

1.8

22.7

355

2046

C07AB07

ATC

bisoprolol; oral

1.4

22.6

1781

14673

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.4

22.6

155

657

SPAT1263

SPAT

Sampling

1.4

22.5

1468

11699

R74

ICPC

Upper respiratory infection acute

1.5

22.5

966

7125

R05

ICD-10 Finland

Cough

1.5

21.5

762

5394

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

21.4

442

2754

N03AX11

ATC

topiramate; oral

3.0

21.4

323

R02

ICPC

Shortness of breath/dyspnoea

1.7

21.3

481

3067

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

21.0

879

6434

P01AB01

ATC

metronidazole; oral, rectal

1.4

20.7

1389

11081

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.1

20.6

194

939

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

20.5

363

2168

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

20.4

766

5483

H29

ICPC

Ear symptom/complaint other

1.7

20.2

408

2526

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.2

20.1

170

788

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

20.1

234

1225

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

19.9

195

959

L12

ICPC

Hand/finger symptom/complaint

1.6

19.8

546

3652

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

19.8

1590

13044

A04

ICPC

Weakness/tiredness general

1.6

19.7

519

3434

L02

ICPC

Back symptom/complaint

1.8

19.7

336

1985

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

19.6

407

2537

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

19.6

116

459

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

19.6

629

4352

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

19.6

200

999

A02BC01

ATC

omeprazole; systemic

1.4

19.5

964

7270

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

19.4

920

6885

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

19.3

1552

12716

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

19.2

257

1408

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

19.0

684

4844

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

19.0

526

3518

L04

ICPC

Chest symptom/complaint

1.9

18.9

232

1235

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

18.9

416

2631

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.3

18.9

151

685

J01CA04

ATC

amoxicillin; systemic

1.4

18.8

2849

25810

J20

ICD-10 Finland

Acute bronchitis

1.7

18.8

352

2134

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

18.7

885

6610

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

18.5

955

7245

S18

ICPC

Laceration/cut

1.4

18.4

1599

13233

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

18.3

2211

19244

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

18.3

1039

8016

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

3.7

18.2

151

R06AE53

ATC

cyclizine, combinations; systemic

4.5

18.2

R21

ICPC

Throat symptom/complaint

1.5

18.2

600

4171

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

3.5

18.1

180

R06AE07

ATC

cetirizine; oral

1.4

18.0

1489

12213

L15

ICPC

Knee symptom/complaint

1.4

17.9

836

6225

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

17.9

183

915

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

17.8

352

2165

C10AA05

ATC

atorvastatin; oral

1.4

17.8

1474

12087

SPAT1043

SPAT

Audiometry

1.7

17.7

379

2380

R35

ICD-10 Finland

Polyuria

1.9

17.6

239

1316

H01

ICPC

Ear pain/earache

1.7

17.5

362

2251

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

17.5

175

867

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.0

17.4

267

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

17.4

2180

19012

N05BA04

ATC

oxazepam; oral

1.4

17.4

900

6823

D01

ICPC

Abdominal pain/cramps general

1.6

17.3

384

2431

U02

ICPC

Urinary frequency/urgency

1.5

17.3

513

3480

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

17.2

684

4932

M02AA07

ATC

piroxicam; topical

1.4

17.2

1281

10314

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

17.1

398

2550

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

17.1

1079

8457

N06AX21

ATC

duloxetine; oral

1.6

17.1

407

2624

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.2

17.1

138

629

R06.4

ICD-10 Finland

Hyperventilation

3.3

17.1

197

H81.8

ICD-10 Finland

Other disorders of vestibular function

19.3

16.8

J01DA01

ATC

[U] cefalexin

1.3

16.7

2133

18593

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

16.7

383

2447

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

16.6

253

1444

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

16.5

121

529

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

16.5

765

5677

D02

ICPC

Abdominal pain epigastric

1.9

16.5

218

1191

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

16.5

364

2303

L13

ICPC

Hip symptom/complaint

1.5

16.4

671

4862

D06

ICPC

Abdominal pain localized other

1.7

16.4

289

1722

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

16.4

204

1093

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

16.3

267

1556

J01FA06

ATC

roxithromycin; oral

1.3

16.3

1373

11246

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

16.2

127

571

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

16.2

146

695

K08.80

ICD-10 Finland

Toothache NOS

1.7

16.2

277

1635

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.9

16.2

212

1155

J02AC01

ATC

fluconazole; systemic

1.3

16.1

1350

11040

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

16.1

477

3235

G43.8

ICD-10 Finland

Other migraine

3.3

16.0

180

H66.9

ICD-10 Finland

Otitis media, unspecified

2.0

15.9

180

933

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

15.7

227

1275

R4110, ,

SPAT

1.7

15.7

313

1928

K02.1

ICD-10 Finland

Caries of dentine

1.3

15.6

1877

16153

XKD00

NOMESCO Finland

Uroflowmetry

1.5

15.6

476

3247

M54.3

ICD-10 Finland

Sciatica

1.9

15.5

213

1177

SPAT1104

SPAT

Monitoring of emergency patient

1.8

15.5

241

1384

SPAT1312

SPAT

General health counselling

1.4

15.5

1039

8199

J01

ICD-10 Finland

Acute sinusitis

1.9

15.5

182

956

R01AD12

ATC

fluticasone furoate; nasal

1.4

15.5

972

7589

L28

ICPC

Limited function/disability (L)

1.5

15.5

644

4679

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

15.4

2396

21371

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

15.4

122

552

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

3.5

15.3

155

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.8

15.3

215

1197

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

15.3

344

2185

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.6

15.3

362

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

15.1

351

2248

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

15.0

232

1331

A01

ICPC

Pain general/multiple sites

1.6

14.9

323

2033

G04BD12

ATC

mirabegron; oral

1.5

14.8

428

2882

SPAT1310

SPAT

Counselling related to known health issue

1.4

14.8

1068

8515

D82

ICPC

Teeth/gum disease

1.3

14.8

1133

9116

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

14.8

857

6598

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

14.7

137

661

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

14.6

147

731

H80.1

ICD-10 Finland

Otosclerosis involving oval window, obliterative

+∞

14.6

D11

ICPC

Diarrhoea

1.6

14.5

363

2364

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

14.5

968

7617

A03

ICPC

Fever

1.5

14.5

481

3339

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

14.5

131

626

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.1

14.4

197

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.1

14.4

192

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.7

14.4

279

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

14.4

353

2291

C09CA06

ATC

candesartan; oral

1.4

14.3

800

6115

M75.8

ICD-10 Finland

Other shoulder lesions

2.1

14.3

130

622

M01AX17

ATC

nimesulide; oral

1.4

14.2

833

6419

N06AB04

ATC

citalopram; systemic

1.4

14.1

697

5219

D09

ICPC

Nausea

2.1

14.0

139

688

M54

ICD-10 Finland

Dorsalgia

1.6

14.0

387

2581

DFE00

NOMESCO Finland

Insertion of cochlear implant

10.9

14.0

A98

ICPC

Health maint/preventive medicine

1.7

13.9

3531

33861

C03EA02

ATC

trichlormethiazide and potassium-sparing agents; oral

2.7

13.9

290

SFA30

NOMESCO Finland

Three-surface restoration

1.3

13.9

1365

11360

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

13.8

830

6416

X58

ICD-10 Finland

Exposure to other specified factors

1.5

13.8

423

2886

C01DA14

ATC

isosorbide mononitrate; oral

1.5

13.8

516

3668

C05AA08

ATC

fluocortolone; rectal, topical

1.5

13.7

460

3196

H13

ICPC

Plugged feeling ear

1.4

13.7

645

4782

R03BA08

ATC

ciclesonide; inhalant

1.6

13.7

296

1860

C10AA07

ATC

rosuvastatin; oral

1.3

13.6

1070

8618

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

13.6

355

2336

DE2CF

NOMESCO Finland

Acoustic channel extensive MRI examination with median intensity magnet

140.5

13.5

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

13.4

1404

11767

R25.2

ICD-10 Finland

Cramp and spasm

2.4

13.4

379

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

13.4

288

1807

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

13.4

569

4140

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.2

13.4

118

558

U05

ICPC

Urination problems other

1.9

13.4

180

989

M79.7

ICD-10 Finland

Fibromyalgia

2.1

13.3

123

592

N02BF01

ATC

gabapentin; oral

1.7

13.3

276

1716

L14

ICPC

Leg/thigh symptom/complaint

1.7

13.3

269

1664

S02

ICPC

Pruritus

2.1

13.2

120

574

K59.0

ICD-10 Finland

Constipation

1.8

13.2

191

1074

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.7

13.2

112

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

13.1

141

718

H02AB07

ATC

prednisone; oral

1.5

13.1

466

3275

A02BC04

ATC

rabeprazole; oral

1.6

13.1

293

1857

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

13.1

196

1113

SFA20

NOMESCO Finland

Two-surface restoration

1.3

13.1

1862

16235

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

13.1

762

5855

R31

ICD-10 Finland

Unspecified haematuria

1.6

13.1

319

2066

N06AA09

ATC

amitriptyline; systemic

1.6

13.1

342

2252

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

13.0

230

1372

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

12.9

527

3804

SFA10

NOMESCO Finland

One-surface restoration

1.3

12.9

1754

15191

C08CA01

ATC

amlodipine; oral

1.3

12.9

1336

11167

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

3.0

12.9

184

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

12.7

832

6508

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

12.6

599

4445

38699, ,

ICD-8 Finland

+∞

12.5

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.1

12.5

124

614

C01CA24

ATC

epinephrine; parenteral

1.8

12.5

195

1122

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

12.5

424

2953

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.4

12.4

131

Z71.8

ICD-10 Finland

Other specified counselling

1.3

12.4

964

7733

R03BA02

ATC

budesonide; inhalant

1.4

12.4

583

4317

SPAT1254

SPAT

Administration of medicine

1.5

12.4

487

3491

K80

ICPC

Cardiac arrhythmia NOS

1.6

12.3

276

1750

M54.8

ICD-10 Finland

Other dorsalgia

1.9

12.3

149

791

S22.3

ICD-10 Finland

Fracture of rib

1.7

12.3

229

1385

SPAT1153

SPAT

Removal of sutures

1.3

12.3

1081

8825

SPAT1360

SPAT

Extensive global examination

1.7

12.3

235

1432

WX290

NOMESCO Finland

Other blockage of nerve

1.3

12.2

1379

11640

78050

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Vertigo

3.2

12.2

143

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

12.2

186

1064

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

12.2

1400

11842

C07AB02

ATC

metoprolol; systemic

1.4

12.1

685

5229

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

12.1

407

2826

N06AX16

ATC

venlafaxine; oral

1.5

12.1

435

3062

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

12.1

244

1507

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

12.1

235

1438

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.1

12.1

113

548

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

12.0

282

1808

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.0

12.0

124

623

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

12.0

324

2147

M48.0

ICD-10 Finland

Spinal stenosis

1.5

12.0

427

3000

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

12.0

1276

10679

N05AH04

ATC

quetiapine; oral

1.4

12.0

519

3786

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

2.6

11.9

260

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

11.9

412

2879

N03AX09

ATC

lamotrigine; oral

2.0

11.9

131

674

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

11.9

126

640

M02AA10

ATC

ketoprofen; topical

1.4

11.8

531

3901

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

11.8

756

5889

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

11.7

1219

10162

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

11.7

222

1350

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

11.7

282

1822

H71

ICD-10 Finland

Cholesteatoma of middle ear

3.2

11.6

142

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

11.6

239

1484

J01MA12

ATC

levofloxacin; systemic

1.4

11.6

602

4530

M77.1

ICD-10 Finland

Lateral epicondylitis

1.7

11.6

220

1338

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

11.5

573

4281

ACC51

NOMESCO Finland

Release of median nerve

1.6

11.5

251

1583

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

11.4

284

1847

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

11.4

294

1928

H53.2

ICD-10 Finland

Diplopia

2.0

11.4

113

560

D10

ICPC

Vomiting

1.9

11.4

147

798

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

11.4

717

5565

N06AB10

ATC

escitalopram; oral

1.4

11.3

595

4484

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

11.3

365

2513

S29

ICPC

Skin symptom/complaint other

1.4

11.3

626

4759

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

11.3

1169

9730

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

11.3

268

1725

K07.60

ICD-10 Finland

Snapping jaw

1.8

11.2

158

882

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.2

11.2

398

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

11.2

117

592

H81

ICPC

Excessive ear wax

1.4

11.1

570

4277

R29

ICPC

Respiratory symptom/complaint other

1.7

11.1

216

1322

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

11.1

258

1652

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

11.1

273

1772

R06AX27

ATC

desloratadine; oral

1.3

11.0

852

6811

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

11.0

614

4672

J01CA08

ATC

pivmecillinam; oral

1.3

11.0

1412

12064

A06AC51

ATC

ispaghula, combinations; oral

1.8

11.0

160

903

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

11.0

218

1342

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

10.9

3139

29626

H25.8

ICD-10 Finland

Other senile cataract

1.5

10.8

392

2762

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

10.8

430

3086

CS494

NOMESCO Finland

Other visual field testing

2.2

10.8

431

DFX00

NOMESCO Finland

Connecting cochlear implant

10.6

10.8

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

10.7

291

1930

B01AC04

ATC

clopidogrel; oral

1.4

10.7

528

3935

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

10.7

181

1067

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

10.7

238

1508

SPAT1216

SPAT

Assessment of functional ability

1.4

10.6

531

3966

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

10.6

108

541

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

10.6

161

920

S00.0

ICD-10 Finland

Superficial injury of scalp

2.3

10.6

363

N30.0

ICD-10 Finland

Acute cystitis

1.4

10.6

545

4093

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

10.5

618

4738

P06

ICPC

Sleep disturbance

1.5

10.5

340

2341

J02AC02

ATC

itraconazole; systemic

1.4

10.5

572

4337

WZC00, ,

SPAT

1.5

10.4

306

2065

R13

ICD-10 Finland

Dysphagia

1.6

10.4

232

1471

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

10.4

138

757

R03DC03

ATC

montelukast; oral

1.4

10.4

514

3834

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.5

10.3

255

P03

ICPC

Feeling depressed

1.6

10.3

254

1649

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

10.3

355

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

10.2

194

1180

R07.0

ICD-10 Finland

Pain in throat

1.7

10.2

194

1181

SGA01

NOMESCO Finland

Emergency treatment

1.4

10.2

447

3266

J01DA09

ATC

[U] cefadroxil

1.3

10.1

818

6572

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

10.1

185

1115

P01

ICPC

Feeling anxious/nervous/tense

1.5

10.1

288

1933

H60

ICD-10 Finland

Otitis externa

1.8

10.1

148

838

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

10.0

630

4879

SPAT1260

SPAT

Consultation of another employee

1.4

10.0

566

4313

N02CC05

ATC

almotriptan; oral

2.0

10.0

108

553

J01DC02

ATC

cefuroxime; systemic

1.7

10.0

170

1005

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

9.9

598

4601

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

9.9

375

2664

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

9.9

472

3497

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

9.8

149

852

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

9.8

421

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

9.8

221

1406

TAB00

NOMESCO Finland

Lumbar puncture

1.8

9.8

134

743

J01EA01

ATC

trimethoprim; systemic

1.3

9.8

891

7271

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

9.8

363

2571

G04CA02

ATC

tamsulosin; oral

1.3

9.7

636

4954

SPAT1283

SPAT

Restricted health certificate

1.4

9.7

394

2837

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.9

9.7

119

637

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

9.7

314

2165

A97

ICPC

No disease

1.4

9.6

562

4301

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

9.6

209

1316

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

9.6

634

4942

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.4

9.6

264

AA1BG, ,

SPAT

2.5

9.6

240

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

9.6

237

1540

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

9.6

242

1581

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

9.5

148

852

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

9.5

812

6564

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.8

9.5

160

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

9.5

454

3363

C10AA01

ATC

simvastatin; oral

1.2

9.5

1435

12438

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

9.5

320

2225

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.5

9.4

218

R00.8

ICD-10 Finland

Other and unspecified abnormalities of heart beat

2.7

9.4

189

L50.8

ICD-10 Finland

Other urticaria

2.5

9.4

242

S82

ICPC

Naevus/mole

1.4

9.4

417

3050

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.1

9.4

415

38599

ICD-8 Finland

Ménière's disease

+∞

9.4

3861A

ICD-9 Finland

Vertiginous syndromes and other disorders of vestibular system, Other and unspecified peripheral vertigo

+∞

9.4

N05CF01

ATC

zopiclone; oral

1.3

9.4

1079

9059

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

9.4

136

768

N89

ICPC

Migraine

2.1

9.3

389

N03AE01

ATC

clonazepam; systemic

1.7

9.3

185

1139

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

9.3

376

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

9.3

312

2167

D33.30

ICD-10 Finland

Acoustic neuroma

3.6

9.3

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

9.2

212

1354

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.9

9.2

107

563

M01AC06

ATC

meloxicam; systemic, rectal

1.3

9.2

1216

10372

SDA03

NOMESCO Finland

Periodontal treatment

1.3

9.2

1213

10344

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

9.2

159

945

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

9.2

295

2031

N62

ICD-10 Finland

Hypertrophy of breast

1.8

9.1

128

717

A03FA02

ATC

cisapride; oral, rectal

1.5

9.0

248

1651

H83.0

ICD-10 Finland

Labyrinthitis

36.8

9.0

DE2CM

NOMESCO Finland

Acoustic channel extensive MRI examination with 3 Tesla magnet

7.0

9.0

H61.2

ICD-10 Finland

Impacted cerumen

1.6

9.0

212

1363

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

9.0

274

1865

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

9.0

214

1379

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.3

9.0

304

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

2.5

9.0

206

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

8.9

1314

11331

J01FF01

ATC

clindamycin; systemic

1.3

8.9

852

6984

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

8.9

178

1099

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

8.9

148

870

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

8.9

266

1804

R50.9

ICD-10 Finland

Fever, unspecified

1.4

8.9

442

3298

G04CB01

ATC

finasteride; oral

1.5

8.8

290

2004

M01AH01

ATC

celecoxib; oral

1.3

8.8

583

4543

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

8.8

341

2432

I20.09

ICD-10 Finland

Unstable angina

1.6

8.8

177

1094

H03AA01

ATC

levothyroxine sodium; systemic

1.3

8.8

786

6385

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

8.8

420

3110

K07.61

ICD-10 Finland

Cracking jaw joint

2.4

8.8

238

L86

ICPC

Back syndrome with radiating pain

1.6

8.8

192

1212

WZC30, ,

SPAT

1.7

8.8

173

1064

H81

ICD-10 Finland

Disorders of vestibular function

8.6

8.8

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.2

8.8

346

N03AG01

ATC

valproic acid; systemic, rectal

1.7

8.7

170

1042

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

8.7

205

1318

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

8.7

686

5481

H01.0

ICD-10 Finland

Blepharitis

1.6

8.7

187

1176

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.2

8.6

335

H60.8

ICD-10 Finland

Other otitis externa

2.0

8.6

457

H83.3

ICD-10 Finland

Noise effects on inner ear

4.6

8.6

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

8.6

403

2976

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

8.6

485

N06AX26

ATC

vortioxetine; oral

1.6

8.5

186

1174

A04AA01

ATC

ondansetron; systemic, rectal

1.5

8.5

255

1730

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

8.5

255

1730

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

8.5

1392

12129

C08CA13

ATC

lercanidipine; oral

1.4

8.5

473

3591

R06AE09

ATC

levocetirizine; oral

1.4

8.5

422

3147

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

8.5

192

1224

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

8.4

1647

14615

R30.0

ICD-10 Finland

Dysuria

1.8

8.4

127

726

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

8.4

103

552

Z00.8

ICD-10 Finland

Other general examinations

1.5

8.4

222

1466

H25.0

ICD-10 Finland

Senile incipient cataract

1.6

8.4

218

1434

SPAT1301

SPAT

No procedures

1.3

8.4

1006

8467

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

8.4

241

1621

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

8.4

160

977

G50.1

ICD-10 Finland

Atypical facial pain

2.3

8.4

275

WX002

NOMESCO Finland

Sedation and analgesia

1.3

8.3

632

5020

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

8.3

141

833

3870A

ICD-9 Finland

Otosclerosis involving oval window, nonobliterative

+∞

8.3

H80.8

ICD-10 Finland

Other otosclerosis

+∞

8.3

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

8.3

401

M35.7

ICD-10 Finland

Hypermobility syndrome

2.6

8.3

173

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.0

8.2

443

C10AA03

ATC

pravastatin; oral

1.5

8.2

234

1570

W19

ICD-10 Finland

Unspecified fall

1.5

8.2

296

2083

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

8.2

432

3249

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

3.4

8.2

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.3

8.1

253

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

8.1

235

1583

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

8.1

185

1181

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

2.8

8.1

135

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.1

8.1

371

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

8.1

471

3600

R04

ICPC

Breathing problem other

1.8

8.1

117

661

DCD00

NOMESCO Finland

Myringoplasty

3.5

8.1

R52.2

ICD-10 Finland

Other chronic pain

1.8

8.1

115

647

DHB50

NOMESCO Finland

Turbinoplasty

2.1

8.1

365

H60.3

ICD-10 Finland

Other infective otitis externa

2.1

8.1

345

X14

ICPC

Vaginal discharge

2.5

8.1

205

K58

ICD-10 Finland

Irritable bowel syndrome

2.1

8.0

379

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

8.0

100

540

WW200, ,

SPAT

1.3

8.0

710

5759

R03BA05

ATC

fluticasone; inhalant

1.3

8.0

545

4267

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

7.9

1252

10845

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.6

7.9

171

1077

K29

ICPC

Cardiovascular sympt/complt other

1.7

7.9

139

830

G44.8

ICD-10 Finland

Other specified headache syndromes

2.6

7.9

171

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.7

7.9

148

899

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.8

7.9

118

673

N02CC02

ATC

naratriptan; oral

2.3

7.9

244

XQ820

NOMESCO Finland

Exposure to medicinal substance

4.4

7.9

H57.1

ICD-10 Finland

Ocular pain

1.8

7.9

110

615

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

7.9

495

3827

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

7.9

288

2034

M01AH02

ATC

rofecoxib; oral

1.4

7.9

411

3089

K27

ICPC

Fear cardiovascular disease other

2.7

7.9

143

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

7.9

1152

9901

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

7.8

466

ZYC01, ,

SPAT

1.5

7.8

254

1753

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

7.8

946

7960

C09CA01

ATC

losartan; oral

1.3

7.8

840

6973

R06.5

ICD-10 Finland

Mouth breathing

1.5

7.8

247

1696

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

7.8

243

1663

D12

ICPC

Constipation

1.8

7.8

115

654

N05BA12

ATC

alprazolam; oral

1.4

7.8

309

2216

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

7.8

133

789

G43

ICD-10 Finland

Migraine

1.8

7.8

116

662

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

7.8

196

1282

R06.2

ICD-10 Finland

Wheezing

1.7

7.7

128

752

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.8

7.7

109

611

N04BC05

ATC

pramipexole; oral

1.5

7.7

253

1749

D25

ICPC

Abdominal distension

2.2

7.7

298

S02CA02

ATC

flumetasone and antiinfectives; otic

1.6

7.7

166

1046

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.8

7.7

119

687

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

7.7

210

1399

XQ800

NOMESCO Finland

Prick test

1.5

7.6

202

1335

A02BA04

ATC

nizatidine; systemic

1.5

7.6

235

1605

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

7.6

147

901

M54.1

ICD-10 Finland

Radiculopathy

1.7

7.6

122

711

M01AB51

ATC

indometacin, combinations; oral, rectal

2.0

7.6

367

H91.8

ICD-10 Finland

Other specified hearing loss

2.8

7.6

129

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

7.6

192

1257

L05

ICPC

Flank/axilla symptom/complaint

1.6

7.6

185

1201

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.2

7.6

268

ULC02

NOMESCO Finland

Hysteroscopy

1.6

7.5

152

942

N05BA01

ATC

diazepam; systemic, rectal

1.4

7.5

398

2996

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

7.5

112

640

C10AX09

ATC

ezetimibe; oral

1.3

7.5

481

3731

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

7.5

349

2575

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

7.5

800

6633

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.4

2171

19941

Z00.0

ICD-10 Finland

General medical examination

1.3

7.4

581

4630

A99

ICPC

Disease/condition unspecnature/site

1.4

7.4

287

2048

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

7.4

482

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.7

7.4

124

732

AA1CG, ,

SPAT

2.9

7.4

120

EB1VA, ,

NOMESCO Finland

1.4

7.4

352

2607

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

7.4

103

577

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

7.3

139

848

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

7.3

119

696

U07

ICPC

Urine symptom/complaint other

1.5

7.3

228

1560

E0000UV, ,

ATC

1.2

7.3

1314

11511

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.4

7.3

190

R83

ICPC

Respiratory infection other

1.3

7.3

660

5359

DFA00

NOMESCO Finland

Saccotomy

+∞

7.3

3860A

ICD-9 Finland

Vertiginous syndromes and other disorders of vestibular system, Ménière's disease

+∞

7.3

DFD30

NOMESCO Finland

Closure of perilymphatic fistula

+∞

7.3

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

7.3

414

3152

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

7.3

184

1205

J05AB11

ATC

valaciclovir; oral

1.3

7.3

439

3374

J01DA06

ATC

[U] cefuroxime

1.3

7.3

434

3330

G25.0

ICD-10 Finland

Essential tremor

1.9

7.2

443

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

7.2

296

2134

N32.0

ICD-10 Finland

Bladder-neck obstruction

3.4

7.2

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.0

7.2

105

EMB10

NOMESCO Finland

Tonsillectomy

1.7

7.2

124

737

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

7.2

590

4729

-54

ICPC

Repair/fix-suture/cast/prosth device

2.0

7.2

340

M22.4

ICD-10 Finland

Chondromalacia patellae

1.9

7.2

416

UJC12

NOMESCO Finland

Flexible oesophagoscopy

3.1

7.2

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

1.8

7.2

531

D07AC13

ATC

mometasone; topical

1.2

7.1

889

7492

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

7.1

1088

9369

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.9

7.1

410

H83.9

ICD-10 Finland

Disease of inner ear, unspecified

30.1

7.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

7.1

297

2148

G04CA01

ATC

alfuzosin; oral

1.4

7.1

317

2321

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

7.1

220

1505

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

7.1

675

5515

-48

ICPC

Clarification/discussion RFE/demand

2.1

7.1

329

R75

ICPC

Sinusitis acute/chronic

1.6

7.0

141

873

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

7.0

141

873

D03

ICPC

Heartburn

1.8

7.0

106

608

183

Kela drug reimbursment

Lamotrigin and topiramate

3.2

7.0

SPAT1161

SPAT

Ultrasound examination of urinary bladder

3.9

7.0

R01AD11

ATC

triamcinolone; nasal

1.4

7.0

255

1802

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

3.4

7.0

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

7.0

770

6402

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

7.0

793

6616

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

4.4

7.0

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.7

6.9

115

677

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.4

6.9

250

1761

SPAT1211

SPAT

Application of soft bandage

1.4

6.9

267

1904

N29

ICPC

Neurological sympt/complt other

2.1

6.9

292

K04.0

ICD-10 Finland

Pulpitis

1.5

6.9

228

1580

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

6.9

272

1950

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

6.9

672

5507

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.0

6.9

333

U01

ICPC

Dysuria/painful urination

1.5

6.8

236

1649

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

2.9

6.8

103

M01AX05

ATC

glucosamine; oral

1.3

6.8

666

5454

B02AA02

ATC

tranexamic acid; systemic

1.3

6.8

433

3350

N03AX18

ATC

lacosamide; systemic

3.4

6.8

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

6.8

280

L29.2

ICD-10 Finland

Pruritus vulvae

2.3

6.8

222

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

2.9

6.8

109

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.6

6.8

148

937

J01FA01

ATC

erythromycin; systemic

1.4

6.8

370

2800

D01AE16

ATC

amorolfine; topical

1.4

6.8

369

2792

J01DA08

ATC

[U] cefaclor

1.4

6.8

265

1897

P20

ICPC

Memory disturbance

1.3

6.8

448

3489

M01AC01

ATC

piroxicam; systemic, rectal

1.3

6.7

414

3188

K02

ICPC

Pressure/tightness of heart

1.9

6.7

405

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.8

6.7

103

594

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

6.7

134

830

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

6.7

357

2691

JF1BD

NOMESCO Finland

Very extensive small bowel CT

3.4

6.7

G04BD08

ATC

solifenacin; oral

1.5

6.7

211

1449

NG2AA

NOMESCO Finland

Patella X-ray examination

1.8

6.7

499

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.5

6.7

189

1269

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.3

6.7

447

3486

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

6.7

204

1392

K85

ICPC

Elevated blood pressure

1.3

6.7

520

4141

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

6.7

1153

10045

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

6.6

104

603

J45

ICD-10 Finland

Asthma

1.4

6.6

301

2211

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

4.0

6.6

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

6.6

343

2575

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

6.6

558

4489

R60.0

ICD-10 Finland

Localized oedema

1.3

6.6

386

2953

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.8

6.6

101

583

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

3.3

6.5

F32

ICD-10 Finland

Depressive episode

1.6

6.5

137

859

SPAT1236

SPAT

Informing family of child’s disability

2.0

6.5

312

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.2

6.5

252

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.3

6.5

207

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

10.0

6.5

R63.4

ICD-10 Finland

Abnormal weight loss

1.7

6.5

122

743

I84.5

ICD-10 Finland

External hemorrhoids without complication

1.8

6.5

503

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.6

6.5

158

1026

G43.3

ICD-10 Finland

Complicated migraine

2.3

6.5

195

N02BF02

ATC

pregabalin; oral

1.5

6.5

167

1099

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

6.5

212

1467

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.5

6.5

182

1221

-31

ICPC

Medical examin/health eval partial

1.5

6.5

202

1385

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

6.4

124

761

FN1AD

NOMESCO Finland

CT of coronary arteries

2.2

6.4

234

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

6.4

158

1029

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

6.4

487

3864

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

6.4

330

2475

L10

ICPC

Elbow symptom/complaint

1.6

6.4

136

856

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

6.4

521

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

6.4

261

1883

SPAT1240

SPAT

Therapeutic discussion

1.4

6.4

264

1909

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

6.4

551

R01AD05

ATC

budesonide; nasal

1.5

6.4

223

1564

WX722

NOMESCO Finland

PEEP

1.6

6.4

132

826

M01AB55

ATC

diclofenac, combinations; oral

1.5

6.4

216

1506

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

2.3

6.3

197

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

6.3

136

858

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.7

6.3

108

642

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.3

6.3

191

SPAT1325

SPAT

Vaccination

1.2

6.3

1075

9339

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

6.3

150

969

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

6.3

120

734

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

6.3

204

1408

IHZ05, ,

SPAT

1.9

6.3

393

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.5

6.3

174

1163

G01AF05

ATC

econazole; vaginal

1.4

6.3

228

1609

R09.1

ICD-10 Finland

Pleurisy

2.1

6.3

256

L29

ICD-10 Finland

Pruritus

2.3

6.3

192

L90

ICPC

Osteoarthrosis of knee

1.5

6.2

215

1503

H53.4

ICD-10 Finland

Visual field defects

2.0

6.2

311

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

6.2

363

2775

DFF16

NOMESCO Finland

Speech-in-noise audiometry

7.0

6.2

KMAK, ,

NOMESCO Finland

1.2

6.2

1553

13974

R51.81

ICD-10 Finland

Facial pain NOS

1.9

6.2

374

AN1

Coronary angiography

1.4

6.2

332

2505

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.1

6.2

251

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

6.2

617

5064

SPAT1053

SPAT

Memory test

1.3

6.2

466

3693

R06AX13

ATC

loratadine; oral

1.3

6.2

420

3282

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

6.2

160

1055

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.2

781

6584

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

6.2

503

4028

SPAT1229

SPAT

Assessment of need for aid

1.4

6.2

244

1751

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

2.2

6.2

232

XF606

NOMESCO Finland

Ortostatic test

2.9

6.1

R2110

NOMESCO Finland

Giving the first information

1.5

6.1

191

1309

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

6.1

229

1626

L60.0

ICD-10 Finland

Ingrowing nail

1.6

6.1

132

834

FP1B5, ,

SPAT

2.0

6.1

320

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

6.1

259

Z01.7

ICD-10 Finland

Laboratory examination

1.3

6.1

429

3367

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.0

6.1

286

A02BX02

ATC

sucralfate; oral

1.6

6.1

120

741

SPAT1172

SPAT

Guidance concerning hydration

1.9

6.1

369

P25

ICPC

Phase of life problem adult

1.7

6.1

105

626

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.9

6.1

362

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

6.1

226

1602

N05CF02

ATC

zolpidem; oral

1.3

6.1

521

4196

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

6.1

159

1050

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

6.1

106

634

B01AA03

ATC

warfarin; systemic

1.3

6.1

582

4752

G24.9

ICD-10 Finland

Dystonia, unspecified

4.1

6.1

R49.0

ICD-10 Finland

Dysphonia

2.0

6.1

307

M77.4

ICD-10 Finland

Metatarsalgia

1.5

6.1

170

1140

I49.1

ICD-10 Finland

Atrial premature depolarization

1.6

6.1

117

719

SPAT1058

SPAT

PEF monitoring instruction

1.4

6.0

247

1782

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

6.0

280

2064

K04.00

ICD-10 Finland

Hyperemia of pulp

1.7

6.0

113

689

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

1.8

6.0

508

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.0

515

4147

D07AC01

ATC

betamethasone; topical

1.2

6.0

1121

9816

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.0

6.0

281

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.3

6.0

183

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1835

12193

1.99

90.17

4.6

3.7

30.34

90.38

ng/l

0.97

1318

8605

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1531

9703

1.98

84.74

2.3

2.1

132.30

210.72

u/l

5.90

1453

9049

(3013512) EKG study

1504

9502

1.97

83.76

4.8

4.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2089

15018

1.88

76.01

16.6

15.9

1.28

inr

0.02

585

4313

(3013826) Glucose [Moles/volume] in Serum or Plasma

2460

18700

1.92

74.57

4.6

4.7

6.59

6.75

mmol/l

3.90

2349

17495

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

725

3997

2.01

56.07

5.1

4.6

32.05

32.99

1.43

511

2696

(3013707) Erythrocyte sedimentation rate by Westergren method

2831

23462

1.84

54.71

4.8

4.1

11.51

13.05

mm/h

8.25

2606

21613

(3037467) Urinalysis macro (dipstick) panel - Urine

2681

21873

1.79

54.43

5.0

4.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3474

31142

2.57

51.62

17.8

14.9

18.76

24.17

mg/l

23.80

2901

24852

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2923

24640

1.84

51.18

7.7

7.6

74.66

78.97

u/l

8.68

2733

23190

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1955

14804

1.67

50.32

5.2

6.0

1.22

1.21

mmol/l

3.72

1744

13443

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2116

16366

1.67

50.09

5.9

6.7

1.22

1.21

mmol/l

4.46

1766

13878

(3019550) Sodium [Moles/volume] in Serum or Plasma

3554

32339

2.89

48.84

20.2

17.2

139.71

139.65

mmol/l

0.72

3481

31527

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1426

10021

1.68

48.33

2.6

58.56

66.77

u/l

0.48

1281

9237

(3023103) Potassium [Moles/volume] in Serum or Plasma

3557

32422

2.89

47.91

20.3

17.4

3.96

3.97

mmol/l

2.57

3470

31556

(3031040) Bacteria [#/volume] in Urine by Automated count

2582

21200

1.70

47.18

5.5

4.7

135.30

2451.85

e6/l

4.40

297

(3019225) pH of Specimen

609

3347

1.98

46.76

3.9

4.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3282

28984

2.06

46.60

6.0

4.9

1.85

2.12

mu/l

2.06

2984

26430

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2402

19830

1.59

38.31

3.5

3.1

44.78

49.63

u/l

2.46

2194

18304

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2095

16782

1.56

37.96

5.6

6.2

10.93

11.35

umol/l

1.17

1957

15925

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1017

6920

1.64

36.87

1.8

1.7

0.95

1.26

mg/l

3.96

760

5304

(3018677) aPTT in Platelet poor plasma by Coagulation assay

767

4845

1.73

36.81

1.9

2.0

29.25

29.81

2.01

748

4700

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3232

28944

1.84

36.06

6.3

5.9

39.79

40.00

mmol/mol

0.67

2930

26622

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1736

13499

1.53

34.79

2.1

2.0

100.34

95.45

pmol/l

3.22

898

6831

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2817

24421

1.62

34.08

4.8

4.1

14.95

14.86

pmol/l

1.16

2532

22121

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1302

9538

1.56

34.03

3.1

3.0

1085.47

1473.51

ng/l

4.36

1091

8238

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3352

30500

1.93

33.69

5.4

4.7

5.95

5.96

mmol/l

0.08

3022

27657

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3555

33111

2.42

32.74

12.2

10.7

25.55

25.27

u/l

0.32

3409

31873

(40761511) CBC panel - Blood by Automated count

3489

32278

2.16

32.21

17.4

14.1

—

(40768797) Stomach Pathology biopsy report

693

4434

1.69

31.17

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3249

29524

1.75

29.42

16.5

13.9

78.48

78.56

ml/min/173m2

0.08

2802

24409

(3009542) Hematocrit [Volume Fraction] of Blood

3626

34310

2.72

28.09

26.3

22.1

40.06

39.71

3.10

3421

31970

(3007461) Platelets [#/volume] in Blood

3627

34328

2.72

28.01

26.5

22.0

249.45

251.97

e9/l

1.57

3563

33404

(3024731) MCV [Entitic volume]

3627

34340

2.71

27.76

26.3

21.9

90.97

91.25

3.52

3587

33802

(3010813) Leukocytes [#/volume] in Blood

3627

34340

2.71

27.76

26.5

22.0

6.73

6.75

e9/l

0.12

3557

33295

(3035941) MCH [Entitic mass]

3627

34341

2.71

27.74

26.3

21.9

30.28

30.31

0.40

3586

33800

(3026361) Erythrocytes [#/volume] in Blood

3627

34344

2.71

27.68

26.4

22.0

4.47

4.44

e12/l

3.39

3557

33305

(3000963) Hemoglobin [Mass/volume] in Blood

3627

34354

2.70

27.48

26.6

22.1

134.52

133.72

g/l

3.05

3586

33823

(40760892) CBC W Ordered Manual Differential panel - Blood

1818

14737

1.45

27.03

6.4

6.3

—

(3018010) Neutrophils/100 leukocytes in Blood

1836

14926

1.45

26.79

5.9

56.84

57.55

1.74

1705

13916

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2153

18037

1.45

26.76

3.0

2.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

1857

15139

1.45

26.63

6.3

6.1

28.15

27.53

1.60

1720

14129

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

933

6639

1.54

26.47

1.3

1.2

1.40

1.75

u/ml

0.47

210

1721

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

881

6199

1.55

26.27

4.6

3.7

148.61

386.85

ng/l

4.38

682

4957

(3006504) Eosinophils/100 leukocytes in Blood

1804

14724

1.43

25.15

6.2

6.0

2.82

2.84

0.14

1674

13692

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

775

5348

1.57

25.04

1.4

1.3

38.96

32.72

iu/ml

0.47

237

1689

(3019069) Monocytes/100 leukocytes in Blood

1812

14809

1.43

25.03

6.5

6.3

8.38

8.63

2.81

1686

13795

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

370

2098

1.85

24.98

2.6

2.4

17.36

24.81

au/ml

0.69

144

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3382

31362

1.80

24.96

5.7

5.0

2.74

mmol/l

0.10

3095

28726

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

342

1896

1.88

24.78

1.3

46.10

50.47

au/ml

0.17

114

(3007164) IgA [Mass/volume] in Serum or Plasma

822

5777

1.54

24.39

1.4

1.5

2.30

2.49

g/l

1.81

459

3455

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1669

13482

1.43

24.35

2.4

2.2

78.40

78.80

nmol/l

0.23

1486

12009

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3209

29392

1.64

24.14

4.5

4.0

1.34

1.28

mmol/l

4.68

2901

26631

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3320

30698

1.71

23.80

5.1

4.5

4.65

4.67

mmol/l

0.60

3038

28263

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3298

30458

1.69

23.53

5.1

4.4

1.45

1.49

mmol/l

7.65

3008

27861

(3022096) Basophils/100 leukocytes in Blood

1735

14291

1.40

21.75

6.2

6.0

0.69

0.68

0.47

1601

13261

(3013115) Eosinophils [#/volume] in Blood

1934

16248

1.39

21.43

6.0

0.19

e9/l

0.80

1697

14199

(3048689) Calprotectin [Mass/mass] in Stool

545

3589

1.61

21.18

2.3

2.2

129.12

136.94

ug/g

0.19

432

2812

(3009343) pH of Capillary blood

336

1956

1.79

20.70

3.1

3.7

7.42

7.41

0.28

250

(3044640) Blood type and Crossmatch panel - Blood

1305

10300

1.41

20.69

2.3

2.4

—

(3026008) Bacteria identified in Urine by Culture

1330

10546

1.40

20.48

3.4

3.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1704

14088

1.38

20.42

3.8

4.8

35.76

35.21

g/l

4.12

1539

13075

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

338

1982

1.78

20.31

3.1

3.7

5.16

5.17

kpa

0.09

318

1882

(3006315) Basophils [#/volume] in Blood

1869

15716

1.38

20.04

5.9

5.8

0.04

e9/l

0.05

1642

13524

(3019198) Lymphocytes [#/volume] in Blood

1905

16078

1.38

19.91

5.9

5.8

1.98

1.92

e9/l

0.47

1703

14156

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

231

1210

1.97

19.78

3.4

3.9

25.02

24.92

mmol/l

0.24

202

1108

(3013650) Neutrophils [#/volume] in Blood by Automated count

2131

18337

1.38

19.61

8.0

9.1

4.08

4.13

e9/l

0.41

1865

15987

(3022313) Gas panel - Capillary blood

258

1410

1.89

19.46

3.2

3.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

714

5094

1.50

19.18

1.4

1.2

17.44

11.37

u/ml

0.42

252

1930

(3001604) Monocytes [#/volume] in Blood

1856

15670

1.37

18.99

5.9

5.8

0.58

0.59

e9/l

0.59

1636

13489

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

319

1885

1.76

18.63

3.1

3.6

1.61

1.90

mmol/l

0.86

246

1403

(3018095) Leukocytes [#/volume] in Urine

1389

11265

1.37

18.04

4.2

3.7

93.13

112.19

e6/l

0.44

1024

7975

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1020

7873

1.41

17.82

2.2

2.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1602

13316

1.35

17.65

3.0

2.8

118.13

126.55

ug/l

0.52

1462

12265

(3015377) Calcium [Moles/volume] in Serum or Plasma

1386

11284

1.36

17.39

2.9

3.4

2.36

mmol/l

0.01

1171

9837

(3019309) Folate [Moles/volume] in Red Blood Cells

838

6273

1.43

17.34

1.9

1.7

1098.18

1175.90

nmol/l

1.60

622

4725

(3017732) Neutrophils [#/volume] in Blood

346

2143

1.68

17.01

2.7

3.1

4.29

5.16

e9/l

0.87

259

1700

(3000850) Epithelial cells [#/volume] in Urine

890

6759

1.42

16.93

2.9

2.6

5.55

5.91

e6/l

0.43

784

6064

(3026782) Osmolality of Urine

859

6484

1.42

16.91

3.4

2.9

529.21

531.41

mosm/kgh2o

0.11

722

5579

(3037522) Nuclear Ab [Titer] in Serum

582

4088

1.50

16.66

1.4

1.3

553.39

538.45

titre

0.06

127

919

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

295

1761

1.73

16.60

2.4

—

(3002582) Erythrocytes [#/volume] in Urine

1206

9660

1.37

16.59

3.7

3.2

170.79

81.09

e6/l

0.43

953

7418

(3036481) Cortisol [Moles/volume] in Serum or Plasma

431

2841

1.58

16.47

2.1

2.2

368.31

374.47

nmol/l

0.28

386

2603

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1044

8239

1.37

15.57

2.4

2.2

2.96

3.02

mg/l

0.38

879

7004

(40768804) Tissue Pathology biopsy report

1570

13182

1.33

15.48

2.2

2.1

—

(3030467) Casts [#/volume] in Urine by Automated count

1112

8907

1.35

14.96

3.6

3.1

0.40

0.47

e6/l

0.25

863

6795

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1761

15087

1.32

14.81

2.5

2.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

633

4625

1.44

14.68

1.5

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

179

957

1.91

14.46

1.7

—

(36304419) Bacteria [Presence] in Urine

1077

8648

1.34

14.08

3.5

3.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

969

7710

1.35

13.34

1.6

21.23

20.65

nmol/l

0.51

805

6546

(3022145) Colonoscopy Study observation

501

3562

1.47

13.32

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

706

5346

1.39

13.26

2.0

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

418

2.31

12.86

2.1

2.2

25.75

21.82

mg/l

0.30

102

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

899

7110

1.35

12.80

1.8

1.7

32044629.29

30877032.19

pmol/l

0.02

724

5875

(3005322) IgE [Units/volume] in Serum or Plasma

286

1825

1.61

12.46

1.3

93.24

196.97

u/ml

5.74

267

1674

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

240

1508

1.63

11.14

1.1

1.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

496

3643

1.42

10.97

2.3

2.7

7.20

8.57

umol/l

0.53

430

3151

(3025941) Bacteria identified in Stool by Culture

267

1732

1.58

10.86

1.3

—

(36660697) Celiac disease serology panel - Serum

345

2373

1.50

10.75

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1006

8261

1.30

10.65

2.4

2.7

3349.84

5335.69

umol/l

0.98

833

7178

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

209

1288

1.66

10.48

1.9

1.8

39.12

39.13

u/l

0.00

180

1141

(3021601) Nitrite [Presence] in Urine by Test strip

1757

15476

1.25

10.37

5.7

5.2

0.00

estimate

0.50

338

2874

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

207

1279

1.65

10.28

2.0

1.8

—

(3035350) Ketones [Presence] in Urine by Test strip

1758

15499

1.25

10.24

4.2

3.9

0.01

0.00

estimate

0.49

360

3095

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

221

1390

1.63

10.23

2.2

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

1775

15668

1.25

10.22

4.3

3.9

0.00

estimate

0.80

340

2823

(3013139) Helicobacter pylori Ag [Presence] in Stool

318

2174

1.51

10.21

1.3

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

983

8103

1.29

10.00

3.7

3.8

90.49

89.89

0.29

963

7894

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

293

1980

1.52

9.94

1.7

1.6

—

(3049717) Cytology report of Urine Cyto stain

193

1182

1.67

9.92

2.5

2.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

669

5241

1.34

9.85

2.5

3.3

0.82

0.81

mmol/l

0.61

615

4894

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

425

2.10

9.57

1.5

1.4

—

(3015736) pH of Urine

1434

12422

1.25

9.54

3.7

3.6

5.69

5.84

1.00

777

(3005988) Vibrio sp identified in Specimen by Organism specific culture

415

2.10

9.38

1.5

—

(3018418) pH of Serum or Plasma

1157

9796

1.26

9.35

3.6

4.1

7.40

1.04

240

1855

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

376

2.15

9.34

1.4

33.70

32.54

u/l

0.09

314

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

419

2.08

9.16

1.5

1.4

—

(4200892) Spirometry reversibility

321

2249

1.47

9.12

1.5

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

643

5071

1.32

8.98

3.1

2.9

3.23

2.93

e6/l

0.28

374

2751

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

414

2.05

8.69

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

414

2.05

8.69

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

421

2.04

8.68

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

4.25

8.65

1.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

683

5459

1.31

8.63

2.9

2.7

1.01

1.17

e6/l

0.86

410

3120

(3023368) Bacteria identified in Blood by Culture

1048

8845

1.26

8.55

4.2

4.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

155

934

1.69

8.52

1.5

1.6

1.19

1.18

g/l

0.34

149

887

(3044290) Cell count panel - Cerebral spinal fluid

107

588

1.84

8.09

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

130

2.86

8.05

1.1

1.0

7.01

6.72

u/ml

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1000

8451

1.25

7.97

1.7

1.6

1.41

1.35

mmol/l

0.96

825

7044

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

178

1135

1.60

7.85

1.5

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

970

8183

1.25

7.83

4.1

3.5

—

(3000494) Fungus identified in Specimen by Culture

480

3699

1.34

7.80

1.5

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

130

766

1.72

7.78

1.5

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

140

846

1.68

7.65

1.2

9.67

48.36

u/ml

—

(3005719) IgG [Mass/volume] in Serum or Plasma

322

2345

1.41

7.43

2.3

2.8

10.05

10.54

g/l

1.15

290

2138

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1167

10097

1.23

7.37

2.8

3.2

32.71

36.60

u/l

0.70

1091

9566

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

104

3.00

7.34

1.2

0.31

0.30

g/l

0.30

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

146

907

1.63

7.19

1.5

1.6

0.22

0.24

g/l

1.22

140

860

(3009508) Creatinine [Moles/volume] in Urine

1143

9891

1.22

7.16

3.1

7.45

7.17

mmol/l

1.23

925

8313

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

124

740

1.70

7.12

1.2

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

472

3679

1.32

7.08

1.9

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

512

1.84

7.04

1.6

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

225

2.28

7.03

1.3

1.87

2.16

mmol/l

1.86

212

(3032057) Clostridioides difficile [Presence] in Stool

3.40

6.96

1.8

2.0

—

(3002032) Base excess in Venous blood by calculation

390

2966

1.35

6.91

3.2

3.6

2.16

2.02

mmol/l

0.36

341

2512

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

122

732

1.69

6.88

1.3

439.32

543.21

mg/l

2.73

117

688

(40761536) Microorganisms panel - Urine sediment

358

2698

1.36

6.73

5.0

4.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1149

10002

1.21

6.69

3.7

3.8

6.66

9.06

mg/mmol

1.59

681

6228

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

129

796

1.64

6.55

1.3

4.66

7.82

u/ml

0.58

140

(3015171) Extractable nuclear Ab [Units/volume] in Serum

182

1218

1.52

6.54

1.3

1.2

1.35

1.18

u/ml

0.06

113

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

324

2417

1.37

6.49

1.7

1.6

—

(3012516) Albumin [Mass/volume] in Urine

1094

9510

1.21

6.41

3.1

3.2

359.94

341.82

mg/l

0.04

655

5974

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1335

11832

1.20

6.36

4.6

4.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

142

2.55

6.35

1.2

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

150

970

1.57

6.30

1.5

1.4

268.10

277.22

ug/g

0.20

566

(3011288) Drugs identified in Urine by Screen method

444

1.84

6.26

2.5

2.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

277

2030

1.39

6.19

1.3

1.2

107.32

149.44

iu/ml

1.24

107

738

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

107

642

1.69

6.08

1.3

1.2

3.81

3.80

mmol/l

0.06

602

(3030981) Hyaline casts [#/volume] in Urine by Automated count

227

1614

1.43

6.03

3.0

2.8

0.19

0.31

e6/l

1.15

221

1570

(3027008) Opiates [Presence] in Urine

109

659

1.67

6.02

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

152

2.45

6.02

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

152

2.45

6.02

1.3

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

150

981

1.55

6.01

1.2

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

271

1989

1.39

6.01

1.9

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

196

2.26

5.98

1.2

1.3

—

(40768443) Skin Pathology biopsy report

204

1427

1.45

5.92

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

976

8447

1.21

5.91

5.6

5.1

2.76

3.05

ug/l

0.39

870

7515

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

403

1.85

5.86

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

389

1.87

5.85

1.5

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

119

742

1.62

5.84

1.5

1.4

—

(3016879) Cocaine [Presence] in Urine

101

604

1.69

5.82

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

124

782

1.61

5.81

1.3

1.2

4.10

2.87

u/ml

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

258

2.07

5.79

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

199

2.23

5.78

1.2

1.3

—

(3028300) Cannabinoids [Presence] in Urine

108

663

1.65

5.65

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

382

2983

1.31

5.65

3.3

3.6

5.80

5.84

kpa

0.35

376

2895

(3000764) Benzodiazepines [Presence] in Urine

107

656

1.65

5.63

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

453

1.78

5.60

1.3

0.62

0.65

nmol/l

0.41

434

(3027944) Amphetamines [Presence] in Urine

106

650

1.65

5.58

1.5

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

229

1660

1.40

5.48

2.2

11.23

12.18

nmol/l

0.91

196

1466

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

382

2996

1.31

5.47

2.7

2.4

33.04

54.44

u/l

0.70

321

2565

(4034850) Laboratory test

157

1060

1.50

5.46

6.8

10.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

258

2.03

5.42

1.7

1.6

—

(3012501) Base excess in Blood by calculation

116

733

1.60

5.42

4.4

4.6

2.60

2.66

mmol/l

0.10

516

(3033705) Calcium.ionized [Moles/volume] in Venous blood

414

1.80

5.41

2.6

2.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

124

798

1.57

5.37

1.9

11.06

11.65

mg/l

0.34

113

725

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

104

642

1.64

5.35

1.2

3.05

3.20

u/ml

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.87

5.34

2.2

2.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

130

849

1.55

5.28

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

254

1887

1.37

5.26

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

195

2.17

5.21

1.1

—

(3008898) HLA-B27 [Presence]

136

902

1.53

5.16

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

391

1.81

5.16

1.5

1.3

274.59

297.65

pmol/l

0.32

339

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

363

2852

1.30

5.14

3.0

2.9

137.32

200.83

ng/l

5.83

340

2597

(3023511) Choriogonadotropin [Units/volume] in Urine

377

1.82

5.14

1.5

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

421

1.77

5.13

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

127

2.45

5.11

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

184

2.19

5.09

1.1

0.84

5.17

nmol/l

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

334

2600

1.31

5.06

2.6

3.7

75.62

90.12

ng/l

3.65

281

2211

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

462

1.73

4.99

1.3

0.12

0.35

nmol/l

—

(3006653) Thiamine [Moles/volume] in Blood

160

2.26

4.97

1.1

1.3

133.67

132.91

nmol/l

0.04

160

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

292

2238

1.33

4.95

2.0

1.9

—

(3004616) Nuclear Ab [Presence] in Serum

390

1.78

4.91

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

731

6257

1.21

4.86

2.9

3.1

2.45

2.46

mmol/l

1.88

611

5472

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

4.56

4.86

1.0

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

467

1.71

4.82

1.7

1.6

0.58

0.81

g/l

1.98

353

(3027273) Bicarbonate [Moles/volume] in Venous blood

217

1599

1.38

4.75

3.6

3.2

25.51

25.38

mmol/l

0.21

210

1548

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

140

952

1.49

4.75

1.4

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

454

3710

1.25

4.69

3.9

4.2

239.88

248.92

u/l

0.90

425

3499

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

165

2.19

4.65

1.2

1.0

1.06

1.11

u/l

0.32

(3021589) Normoblasts [#/volume] in Blood

1523

13914

1.16

4.61

11.0

9.7

0.00

e9/l

1.84

1283

11325

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

398

1.75

4.61

1.2

1.3

—

nmol/l

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

134

2.32

4.58

1.1

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

245

1852

1.35

4.57

1.7

1.9

1.22

1.43

g/l

1.14

223

1682

(3026389) Candida sp identified in Specimen by Organism specific culture

444

1.70

4.57

1.3

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

430

1.71

4.53

2.5

1.9

91.25

89.37

3.61

425

(3028707) Methadone [Presence] in Urine by Screen method

291

1.87

4.50

1.9

2.1

—

(3000492) Spirometry study

362

2894

1.28

4.50

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

349

2780

1.28

4.46

3.7

3.8

1.23

mmol/l

0.04

312

2406

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

215

2.01

4.45

1.3

1.1

32.90

42.39

mg/l

0.98

181

(3004119) Hemoglobin [Mass/volume] in Venous blood

259

1986

1.33

4.40

3.4

3.1

133.04

127.59

g/l

4.20

253

1935

(3024354) Oxygen [Partial pressure] in Venous blood

312

2456

1.29

4.38

3.2

2.9

4.42

4.56

kpa

0.75

307

2375

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

143

996

1.45

4.33

1.7

—

(3045414) Leukocytes [Presence] in Urine

202

1498

1.37

4.28

1.8

2.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.79

4.28

1.1

1.2

0.64

0.71

umol/24h

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

159

2.15

4.21

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

163

1170

1.41

4.20

1.3

27.69

32.08

iu/l

0.98

128

1004

(1616796) Gas panel - Central venous blood

109

724

1.52

4.18

3.0

3.9

—

(40767503) Oxygen content in Capillary blood by calculation

104

684

1.54

4.17

2.8

2.5

16.74

15.93

1.01

351

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

253

1949

1.32

4.17

3.2

3.3

4.35

4.43

pmol/l

0.75

219

1727

(3014051) Protein [Presence] in Urine by Test strip

128

884

1.46

4.07

2.6

2.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

445

3688

1.23

4.06

1.8

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

152

1085

1.42

4.05

2.7

—

(44813793) Dust mix specific IgE antibody measurement

189

2.02

4.02

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

611

1.55

3.99

1.2

39.37

43.85

u/ml

0.09

(3022948) Iron [Moles/volume] in Serum or Plasma

597

5104

1.20

3.98

2.3

2.5

13.02

12.81

umol/l

0.28

546

4760

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

478

1.62

3.97

1.4

1.6

—

(3045424) Erythrocytes [Presence] in Urine

557

1.58

3.95

1.5

1.6

—

(3038515) Glucose [Moles/volume] in Venous blood

105

702

1.51

3.93

4.9

3.2

7.49

7.60

mmol/l

0.14

105

685

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

520

4397

1.21

3.90

2.3

2.6

21.92

22.39

0.34

443

3741

(3010838) Calcium [Moles/time] in 24 hour Urine

591

1.55

3.89

1.8

4.43

4.85

mmol/24h

0.61

506

(3004789) Transferrin [Mass/volume] in Serum or Plasma

552

4700

1.20

3.85

2.2

2.5

2.39

2.32

g/l

3.01

504

4351

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

207

1.94

3.81

1.3

—

(3000330) Specific gravity of Urine by Test strip

224

1720

1.32

3.81

3.8

3.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

301

1.77

3.79

1.5

1.4

0.38

0.40

g/l

0.18

214

(3028192) IgG subclass 2 [Mass/volume] in Serum

301

1.77

3.79

1.5

1.4

2.83

2.85

g/l

0.03

213

(3027135) IgG subclass 1 [Mass/volume] in Serum

301

1.77

3.79

1.5

1.4

6.30

6.90

g/l

0.65

212

(4062490) Immunoglobulin typing, IgG

301

1.77

3.79

1.5

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

346

2813

1.25

3.76

2.6

2.4

6.58

6.91

ug/l

0.12

288

2463

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.74

3.75

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

171

1264

1.37

3.74

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

182

1359

1.36

3.73

4.6

5.7

1.66

1.59

0.26

171

1273

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

638

1.52

3.71

1.4

1.3

11.14

28.53

e6/l

0.94

488

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

639

1.52

3.69

1.5

1.4

404.48

1355.70

e6/l

1.08

518

(3002256) Pathology report gross observation

504

4272

1.21

3.68

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

412

3423

1.23

3.68

4.2

3.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

180

1346

1.35

3.67

4.6

5.7

0.83

0.89

1.55

169

1263

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

103

2.34

3.66

3.7

2.9

27.67

29.16

umol/l

0.31

(3009214) Lutropin [Units/volume] in Serum or Plasma

600

1.53

3.66

1.3

9.44

12.25

u/l

1.52

488

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

142

2.12

3.64

1.5

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

313

1.74

3.62

2.2

2.9

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

3.51

3.60

1.0

1.1

0.32

1.86

u/ml

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.01

3.59

1.0

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

113

783

1.46

3.58

1.8

1.6

370.35

304.30

mu/l

0.66

706

(3003129) Base excess in Capillary blood by calculation

2.51

3.54

1.3

2.1

0.52

1.45

mmol/l

0.43

(3004588) Protein electrophoresis panel - Serum or Plasma

290

2327

1.27

3.54

1.8

2.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

454

1.60

3.52

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.81

3.52

1.6

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

214

1.88

3.48

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

332

1.70

3.48

4.0

3.5

59.73

56.65

0.44

278

(3020630) Protein [Mass/volume] in Serum or Plasma

340

2789

1.24

3.43

1.9

2.7

66.55

66.44

g/l

0.10

298

2545

(3000475) Leukocytes [#/volume] in Synovial fluid

111

775

1.45

3.40

1.5

1.6

10043.80

13216.77

e6/l

0.46

557

(3029937) Albumin [Presence] in Urine by Test strip

937

8413

1.15

3.40

4.9

4.3

0.01

0.00

estimate

0.24

342

2784

(3014111) Lactate [Moles/volume] in Serum or Plasma

341

2807

1.24

3.34

4.9

6.6

1.36

1.35

mmol/l

0.09

332

2739

(3002385) Erythrocyte distribution width [Ratio]

2778

26764

1.15

3.32

20.0

17.7

15.82

15.12

5.54

2744

26255

(3011985) Renin [Units/volume] in Plasma

415

1.60

3.29

1.4

23.35

47.09

mu/l

1.91

364

(4146454) Self-monitoring of blood glucose

353

1.65

3.29

2.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

436

3688

1.21

3.27

1.8

—

(3008037) Lactate [Moles/volume] in Venous blood

107

748

1.44

3.27

4.8

3.1

1.57

1.60

mmol/l

0.13

107

729

(3004809) Band form neutrophils/100 leukocytes in Blood

544

1.52

3.24

3.7

0.99

1.47

1.29

483

(3016018) Differential panel - Cerebral spinal fluid

301

1.70

3.24

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

491

4203

1.19

3.23

3.7

5.7

1.01

1.04

mmol/l

1.85

451

3888

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

425

3592

1.21

3.21

3.1

4.0

11.07

26.36

ug/l

1.50

337

2922

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

114

810

1.42

3.19

1.0

1.1

2.61

6.33

u/ml

—

(3037121) Protein [Mass/volume] in Urine

151

1127

1.35

3.16

3.7

3.1

0.25

0.29

g/l

0.35

440

(3014765) Yersinia sp identified in Stool by Organism specific culture

129

939

1.39

3.15

1.3

1.2

—

(40758558) Short blood count panel - Blood

907

8164

1.15

3.15

6.2

6.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

476

4078

1.19

3.11

7.0

7.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

351

1.63

3.11

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

148

1106

1.35

3.08

1.9

2.2

353.25

668.65

ug/l

0.59

136

1037

(1761868) Lipid panel - Serum or Plasma

1124

10275

1.13

3.08

3.4

2.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

434

3695

1.20

3.04

2.2

2.5

1.78

1.82

0.31

373

3267

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.51

3.04

1.1

1.0

5.38

11.54

u/ml

—

(42529406) Shigella sp [Presence] in Stool by Culture

129

946

1.38

3.03

1.3

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

255

1.73

3.01

1.1

1.2

93.80

69.30

u/ml

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

276

2250

1.24

2.98

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

183

1.87

2.95

1.0

1.1

9.33

10.18

iu/ml

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

114

2.11

2.94

1.0

1.1

128.83

463.34

ng/l

—

(3019060) Gas panel - Arterial blood

266

2164

1.25

2.93

3.9

5.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.16

2.84

1.1

1.2

1.58

1.75

umol/24h

0.39

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

190

1494

1.29

2.79

5.0

3.7

49.19

48.56

0.14

190

1476

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

211

1682

1.27

2.78

6.3

9.0

24.51

24.43

mmol/l

0.17

201

1630

(3023520) Reticulocytes [#/volume] in Blood

330

2764

1.21

2.77

2.6

2.5

68.81

70.40

e9/l

0.35

269

2080

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

240

1.72

2.73

1.6

1.5

25.60

17.68

u/ml

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.20

2.73

1.3

1.7

—

(3014271) Vancomycin [Susceptibility]

167

1.86

2.71

3.3

3.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

126

939

1.35

2.71

1.6

1.5

0.47

6.94

iu/ml

0.54

199

(3036180) Methadone [Presence] in Urine

2.33

2.65

1.1

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

273

1.66

2.64

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

171

1341

1.29

2.59

1.9

2.0

1.54

2.34

ug/l

0.61

141

1187

(3003396) Base excess in Arterial blood by calculation

431

3723

1.18

2.58

5.5

7.2

1.21

mmol/l

0.01

340

2946

(3048929) Epstein Barr virus Ab [Presence] in Serum

107

784

1.38

2.57

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

163

1.85

2.57

4.5

13.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

200

1.76

2.55

8.4

6.5

—

(3003181) Sodium [Moles/volume] in Urine

625

1.42

2.54

1.5

1.3

72.76

62.54

mmol/l

1.35

504

(3016502) Oxygen saturation in Arterial blood

386

3312

1.18

2.51

5.7

7.6

96.09

95.64

0.77

370

3187

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

431

3734

1.17

2.50

5.5

7.2

4.99

5.10

kpa

1.68

407

3552

(3008757) Leukocyte morphology finding [Identifier] in Blood

357

1.55

2.48

3.8

4.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

180

1.78

2.47

1.1

1.2

—

(40761535) Cells panel - Urine sediment

324

2742

1.20

2.46

4.1

3.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.67

2.45

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

430

3733

1.17

2.43

5.5

7.2

12.58

12.20

kpa

0.77

407

3550

(3039162) Centromere protein B Ab [Units/volume] in Serum

375

1.53

2.43

1.3

45.15

66.19

u/ml

—

(3044889) 12 lead EKG panel

2327

22355

1.11

2.41

4.4

3.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

123

932

1.33

2.41

1.3

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

328

1.56

2.40

1.6

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

5.01

2.40

1.0

0.04

2.64

u/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

344

1.55

2.40

2.6

5.8

6.84

7.38

mmol/l

0.97

291

(3034274) Bile acid [Moles/volume] in Serum --fasting

266

1.62

2.38

1.7

1.8

5.59

8.00

umol/l

0.48

183

(3022621) pH of Urine by Test strip

258

2145

1.22

2.37

3.4

3.2

—

(3023410) Appearance of Cerebral spinal fluid

282

1.60

2.36

1.7

1.4

—

(3036489) Thrombin time

144

1119

1.30

2.36

1.8

1.9

21.84

21.50

0.13

118

975

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.64

2.36

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.09

2.32

1.6

1.5

0.41

0.44

ug/l

0.07

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

162

1.80

2.30

2.6

2.4

—

(3023419) Bacteria identified in Sputum by Culture

495

1.44

2.30

2.4

2.6

—

(3004451) EKG impression Narrative

170

1.77

2.28

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

163

1.79

2.26

1.6

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

134

1.87

2.26

1.9

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

187

1511

1.25

2.25

1.5

1.8

1.50

1.55

g/l

0.27

149

1300

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

156

1.80

2.25

1.1

—

(3006462) Nitrate [Presence] in Urine

156

1.80

2.25

3.3

4.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

709

1.36

2.24

2.1

2.0

4572.97

4399.55

u/l

0.03

291

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

415

1.48

2.24

1.7

2.0

189.02

195.12

pmol/l

0.18

393

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.05

2.21

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.69

2.20

1.1

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

288

1.57

2.19

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

610

1.39

2.18

1.4

1.9

0.88

0.81

nmol/l

0.63

504

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

376

3260

1.17

2.18

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

577

1.39

2.17

1.6

1.8

47.53

42.30

nmol/l

0.85

549

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.62

2.14

2.0

2.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

138

1.82

2.09

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.50

2.05

1.4

2.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

199

1.66

2.05

1.5

1.3

30.00

79.33

titre

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

636

1.36

2.02

4.3

3.9

56.28

57.67

0.40

636

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

517

1.40

2.02

2.1

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.08

2.01

1.5

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

568

5105

1.13

2.00

1.5

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

133

1.81

1.99

1.9

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

133

1.81

1.99

1.9

1.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

148

1.76

1.98

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.15

1.98

1.1

0.12

2.10

u/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

209

1.63

1.97

1.2

1.43

1.04

u/ml

0.16

116

(3010503) CD19 cells [#/volume] in Blood

186

1.67

1.97

2.0

2.1

0.12

0.37

e9/l

0.91

178

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

297

1.52

1.95

6.8

4.8

37.44

82.06

u/ml

0.84

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.55

1.94

1.2

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

4.55

1.94

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.57

1.94

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.45

1.93

1.1

1.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.16

1.88

1.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

228

1.58

1.87

1.2

1.1

32.71

35.35

mmol/l

0.32

197

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

109

846

1.30

1.87

1.3

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

284

1.52

1.87

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.03

1.85

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

488

4367

1.14

1.85

1.6

1.7

—

(3042936) Bacteria identified in Isolate by Culture

506

4539

1.13

1.84

1.9

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

168

1.67

1.80

1.8

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

168

1.67

1.80

1.8

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.58

1.80

1.1

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.05

1.80

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

123

1.79

1.0

5.7

82.38

62.51

mg/l

0.66

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.34

1.77

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

131

1.76

1.77

1.0

1.1

0.50

0.95

u/ml

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

208

1.59

1.76

1.3

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

600

1.34

1.76

1.2

—

242.86

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

125

1.76

1.71

1.0

0.70

0.43

u/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

103

805

1.29

1.70

1.7

1.8

2.71

4.51

iu/l

3.49

285

(3004716) Salmonella sp identified in Stool by Organism specific culture

178

1481

1.21

1.70

1.3

—

(3047181) Lactate [Moles/volume] in Blood

128

1030

1.25

1.67

4.9

6.9

1.37

1.31

mmol/l

0.22

109

907

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

944

0.75

1.66

1.4

1.5

—

(3004775) Volume in Urine collected for unspecified duration

261

1.50

1.63

2.5

2.2

675.41

641.46

0.09

174

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

135

1.71

1.62

1.1

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.38

1.61

2.0

2.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.87

1.60

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.87

1.60

1.2

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

128

1.72

1.60

1.1

1.5

29.82

30.14

umol/l

0.06

123

(3024891) Influenza virus A+B Ag [Presence] in Specimen

751

1.29

1.59

1.2

—

(3016750) Collection duration of Urine

190

1.58

1.59

2.2

2.0

489.57

495.01

min

0.10

144

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.50

1.59

1.3

1.1

—

(3000991) Gas panel - Venous blood

299

2617

1.15

1.59

5.9

8.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

136

1.70

1.58

1.2

1.3

150.43

152.92

mmol/24h

0.07

136

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

121

1.74

1.58

2.5

2.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

111

886

1.26

1.57

4.7

4.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

231

1.52

1.56

1.3

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

158

1314

1.21

1.54

1.7

2.5

3.56

3.64

g/l

0.45

136

1192

(3006442) Creatine [Moles/volume] in Serum or Plasma

208

1.54

1.53

1.6

1.5

73.66

82.17

umol/l

1.47

208

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

158

1316

1.21

1.52

1.7

2.5

7.37

7.42

g/l

0.16

136

1193

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

158

1316

1.21

1.52

1.7

2.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.34

1.52

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

115

1.74

1.52

2.7

2.1

46.47

49.09

umol/l

0.15

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

249

1.49

1.52

1.4

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.83

1.51

1.0

1.2

43.06

38.64

g/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

108

1.76

1.50

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

291

1.45

1.50

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

276

1.45

1.46

1.1

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

211

1.52

1.45

1.4

1.3

1.69

1.20

promille

0.85

163

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.13

1.44

1.8

1.6

230.20

346.87

umol/24h

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.73

1.43

1.0

1.3

—

1.14

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

350

3126

1.13

1.41

1.9

2.2

0.22

0.21

g/l

2.14

325

2916

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

181

1.55

1.39

1.1

1.2

1.01

1.04

ratio

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

113

919

1.24

1.39

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

441

1.34

1.39

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

147

1230

1.20

1.38

1.8

2.6

2.88

2.95

g/l

0.39

125

1107

(3025159) Blasts/100 leukocytes in Blood

276

2432

1.15

1.37

3.9

4.2

0.57

0.45

0.08

674

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.61

1.36

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.83

1.35

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

307

1.41

1.34

1.6

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

709

1.26

1.33

2.1

2.3

129.92

127.23

g/l

0.42

516

(3044927) Protein electrophoresis panel - Urine

350

1.38

1.32

1.1

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

290

2573

1.14

1.31

4.2

0.13

0.12

0.10

103

810

(3002173) Hemoglobin [Mass/volume] in Arterial blood

341

3058

1.13

1.30

6.2

8.0

123.68

120.56

g/l

2.29

329

2972

(3020779) Urea [Moles/volume] in Serum or Plasma

320

2859

1.13

1.30

4.1

7.2

9.26

10.16

mmol/l

1.54

295

2724

(3015076) Soybean IgE Ab [Units/volume] in Serum

106

1.70

1.29

1.1

1.0

0.09

0.29

u/ml

—

(3032773) Endomysium IgG Ab [Titer] in Serum

234

1.46

1.29

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

153

1.57

1.28

1.1

—

9.06

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.89

1.28

1.2

1.3

—

(3019150) Specific gravity of Urine by Refractometry

728

6794

1.09

1.28

4.6

4.3

1.02

kg/l

0.28

135

1012

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

677

1.26

1.28

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

677

1.26

1.28

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

134

1121

1.20

1.28

2.0

2.6

1.04

1.07

g/l

0.02

106

975

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.79

1.27

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.79

1.27

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

388

1.34

1.26

1.5

61.67

59.41

0.15

242

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

219

1.47

1.25

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

192

2212

0.86

1.24

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

117

0.43

1.24

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

424

1.33

1.24

1.2

1.1

122.18

117.92

0.43

378

(3052851) Hemolysis interference index of Serum or Plasma

120

997

1.21

1.24

3.5

3.4

—

(3000285) Sodium [Moles/volume] in Blood

2.00

1.23

1.2

1.1

—

(3021901) Oxygen saturation in Capillary blood

592

1.27

1.22

2.4

2.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.63

1.21

3.2

5.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.63

1.21

1.2

1.1

—

0.13

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

1229

1.19

1.21

1.8

2.6

10.27

10.30

g/l

0.03

122

1097

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

737

1.24

1.20

1.2

1.3

181.59

212.37

miu/ml

0.40

324

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

164

1.53

1.20

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

444

1.31

1.19

1.2

5.00

4.65

u/ml

0.07

185

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

123

1029

1.20

1.19

1.9

2.4

39.06

37.78

g/l

1.55

101

905

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.75

1.18

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

367

1.34

1.17

1.4

1.9

—

3.75

—

(3005033) Fetal Nuchal fold Thickness US

370

0.67

1.17

1.2

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.71

1.17

1.1

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

302

2711

1.12

1.16

4.1

0.82

0.91

0.25

117

944

(3010144) Erythrocytes [#/volume] in Synovial fluid

308

1.37

1.15

1.3

1.4

231403.13

96307.22

e6/l

0.39

212

(3008401) Mugwort IgE Ab [Units/volume] in Serum

379

1.32

1.12

1.1

0.39

1.27

u/ml

1.58

159

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.67

1.10

1.3

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.76

1.06

1.0

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

445

4101

1.10

1.06

5.4

6.6

104.86

104.22

mmol/l

2.33

445

4096

(3003888) Timothy IgE Ab [Units/volume] in Serum

392

1.31

1.05

1.1

4.01

4.47

u/ml

0.08

195

(3047352) Trisomy 18 risk [Likelihood] in Fetus

372

0.70

1.05

1.2

1.4

—

(3006270) Folate [Moles/volume] in Blood

288

1.36

1.04

1.3

1.2

329.77

359.79

nmol/l

0.37

245

(3005570) Glucose [Moles/volume] in Urine

340

1.33

1.04

1.8

1.9

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.27

1.03

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

106

1.61

1.02

1.2

1.4

86.65

142.60

nmol/24h

0.45

106

(3003740) Influenza virus B Ag [Presence] in Specimen

385

1.30

1.02

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

381

0.71

1.01

1.3

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

177

0.56

1.01

1.0

1.1

—

(3024928) Oxygen saturation in Venous blood

645

1.23

1.01

2.1

2.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

774

1.21

0.99

2.1

2.2

130.98

100.41

ug/min

0.31

473

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.67

0.97

1.4

1.3

62.44

32.45

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.63

0.97

1.0

1.1

99.33

88.98

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.63

0.97

1.0

1.3

107.17

85.63

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

165

1.46

0.96

1.6

1.8

2.60

2.06

u/field

0.10

114

(3025018) Bordetella pertussis Ab [Titer] in Serum

165

1.46

0.96

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

182

1.43

0.95

1.1

1.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

273

2471

1.11

0.95

4.0

3.9

0.57

0.70

0.59

103

813

(3006922) Hepatitis E virus Ab [Presence] in Serum

191

1.42

0.94

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

225

1.38

0.94

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

225

1.38

0.94

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

225

1.38

0.94

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

788

7470

1.07

0.94

4.0

3.8

—

(40768446) Kidney Pathology biopsy report

116

0.52

0.94

1.2

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

373

1.29

0.94

1.5

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

183

1.42

0.93

1.1

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

286

1.33

0.93

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

286

1.33

0.93

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

286

1.33

0.93

1.7

1.6

—

(3042631) Mycobacterium sp identified in Specimen

463

1.26

0.92

3.4

2.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

313

1.31

0.91

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.14

0.91

1.3

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

176

1.42

0.90

2.0

1.3

1.35

1.14

nmol/l

0.39

138

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

195

0.61

0.90

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

701

1.20

0.89

2.4

3.2

258.43

814.21

u/ml

0.78

643

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.65

0.88

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

386

1.27

0.88

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

216

1940

1.12

0.87

1.4

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

335

3080

1.10

0.87

1.3

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.58

0.87

1.9

1.5

8.91

9.04

ug/l

0.03

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.86

0.87

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

246

1.34

0.87

1.1

1.0

1.32

0.16

u/ml

0.42

(3045788) Cell count panel - Pleural fluid

322

0.71

0.86

1.4

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

264

1.33

0.86

1.7

2.2

6.07

1.85

u/field

0.74

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

344

3170

1.09

0.85

1.6

1.7

1.49

1.48

0.18

297

2752

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

560

1.22

0.84

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

193

1728

1.12

0.83

7.8

10.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

345

1.28

0.83

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

716

6799

1.07

0.82

4.6

4.4

23.13

21.76

1.65

391

3432

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.55

0.81

1.3

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.58

0.81

1.3

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

121

1054

1.15

0.80

1.4

—

(3019977) pH of Arterial blood

181

1.38

0.79

2.8

2.7

7.42

0.01

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.77

0.76

1.3

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.77

0.76

1.3

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

770

1.17

0.76

2.6

3.0

1.57

1.61

mg/l

0.13

695

(3028433) Virus identified in Specimen by Culture

107

1.50

0.76

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

297

1.28

0.75

1.1

4.93

2.42

u/ml

0.37

132

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

486

1.22

0.75

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.08

0.74

2.2

2.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

471

1.21

0.71

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

471

1.21

0.71

1.2

1.1

97.50

1263.43

iu/ml

—

106

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

701

1.17

0.71

1.3

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

520

4914

1.07

0.71

3.2

3.1

0.76

0.78

ug/l

0.16

382

3364

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

105

916

1.15

0.70

2.0

2.5

0.00

g/l

-0.00

843

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.92

0.70

1.0

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

554

1.19

0.70

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

381

1.24

0.70

1.0

1.1

3.22

2.85

u/ml

—

150

(1002224) Polysomnography panel

123

1086

1.14

0.70

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

0.70

1.3

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

112

983

1.14

0.69

2.0

2.5

0.03

0.02

g/l

0.29

906

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

456

1.21

0.67

1.2

1.58

3.46

u/ml

1.35

142

(40759836) Histone Ab [Presence] in Serum by Immunoblot

223

1.30

0.66

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

223

1.30

0.66

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.79

0.66

1.2

1.4

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.79

0.66

3.0

2.1

1.62

1.45

mg/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

430

1.21

0.66

1.6

1.7

—

(3021788) Differential panel - Synovial fluid

587

1.18

0.65

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

224

1.30

0.64

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

120

1.42

0.64

1.4

1.9

17.63

19.47

ug/l

0.24

108

(3008152) Bicarbonate [Moles/volume] in Arterial blood

225

2068

1.09

0.64

6.0

7.1

24.77

24.62

mmol/l

0.21

212

1965

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.73

0.64

1.2

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.50

0.63

2.9

7.04

7.58

mg/l

0.13

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

190

1.32

0.62

1.0

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

147

1.36

0.61

1.9

2.4

1492.75

1166.61

u/ml

0.14

147

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.67

0.61

4.0

12.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

416

1.20

0.61

5.3

5.1

344.55

360.80

umol/l

0.35

360

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.0

—

(3044941) Cell count panel - Synovial fluid

518

1.18

0.60

1.5

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

583

1.17

0.60

1.8

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

367

0.79

0.60

1.4

42683.33

76752.39

e6/l

0.68

211

(3023183) Ammonium ion [Moles/volume] in Plasma

658

1.16

0.59

2.5

2.7

32.18

35.95

umol/l

0.73

587

(3024316) Viscosity of Plasma

0.00

0.59

0.0

1.5

—

1.83

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

166

1.33

0.58

5.5

4.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

113

0.62

0.58

1.1

2.5

—

24037.62

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

857

1.14

0.58

2.0

2.3

3.70

3.63

g/l

0.19

803

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.67

0.56

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.67

0.56

1.3

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

606

1.16

0.56

2.7

2.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.54

0.55

1.3

—

(3003338) MCHC [Mass/volume]

2552

25846

0.96

0.55

21.9

19.4

332.15

331.54

g/l

2.86

2540

25636

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.58

0.54

1.2

1.1

—

(3039000) Anion gap in Blood

721

1.14

0.53

5.7

8.2

11.46

11.10

mmol/l

0.39

646

(3018572) Chloride [Moles/volume] in Blood

721

1.14

0.53

5.7

8.2

105.10

105.11

mmol/l

0.01

646

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.52

0.52

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

907

0.88

0.52

2.0

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

215

0.74

0.52

1.4

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

808

1.13

0.52

1.5

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

219

2035

1.08

0.51

7.0

8.6

94.47

93.89

0.68

219

2029

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

100

1.40

0.51

2.8

1.7

—

(40768800) Prostate Pathology biopsy report

543

0.85

0.51

1.2

—

(3008295) Osmolality of Serum or Plasma

342

1.20

0.51

1.9

1.4

280.51

276.43

mosm/kgh2o

0.53

263

(3051101) Glucose [Moles/volume] in Cord blood

1.39

0.50

3.2

6.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

801

1.13

0.50

1.6

1.4

114.31

203.13

pmol/l

1.71

785

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

412

0.82

0.50

1.4

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

519

1.16

0.50

1.1

1.2

388.97

276.62

u/ml

0.68

315

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

114

1030

1.11

0.49

1.7

3.19

4.07

mg/l

0.53

771

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

110

1.37

0.48

1.1

1498.40

1603.56

miu/ml

0.19

110

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

446

1.17

0.48

1.1

0.64

1.86

u/ml

1.53

231

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

101

908

1.12

0.48

2.1

2.5

0.00

g/l

-0.00

842

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

634

1.14

0.48

1.5

1.6

—

(40758292) HTLV I+II Ab panel - Serum

1.49

0.47

1.1

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

233

0.77

0.47

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

834

1.12

0.47

2.3

194.27

193.74

0.02

792

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.46

0.46

1.6

1.4

93.71

122.38

ug/l

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

504

1.15

0.46

1.5

1.3

—

(3020650) Glucose [Presence] in Urine

0.62

0.45

1.4

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

524

1.15

0.45

1.0

1.2

—

(3045142) Bone marrow Pathology biopsy report

375

1.18

0.45

1.2

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

121

1.32

0.44

1.6

1.8

—

(3048879) Bone marrow aspiration report

1.37

0.43

2.8

1.7

—

(3018133) Calcium [Moles/volume] in Urine

1.61

0.43

1.0

1.6

2.33

2.79

mmol/l

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

359

1.17

0.42

1.2

55.14

58.78

u/l

0.29

324

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

359

1.17

0.42

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

0.65

0.42

2.5

2.0

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

360

0.83

0.42

1.5

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

360

0.83

0.42

1.5

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.56

0.42

2.6

3.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.56

0.42

1.0

2.7

0.40

0.75

u/field

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.56

0.42

1.2

1.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.56

0.42

1.0

—

7.38

—

(3020393) Adenovirus Ag [Presence] in Stool

1.56

0.42

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.40

0.42

1.3

1.4

109.50

104.08

ng/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

369

1.17

0.41

1.9

2.3

0.63

1.34

g/24h

2.37

184

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.43

0.41

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

323

1.18

0.41

1.3

1.4

—

21.20

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.41

0.0

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.41

0.0

4.1

—

17.19

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

9.6

—

171.82

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

12.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.39

0.40

1.1

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

518

0.87

0.40

1.5

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.43

0.39

1.4

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

1.41

0.39

1.0

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.39

0.0

6.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.39

0.0

1.5

—

23.73

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.39

0.0

3.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

288

1.18

0.39

2.4

2.2

—

(3047189) Immunofixation for 24 hour Urine

170

0.76

0.38

1.3

1.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

108

991

1.09

0.38

3.6

4.0

3.82

3.87

mmol/l

0.70

108

982

(3052592) Norovirus Ag [Presence] in Stool

1.34

0.38

1.1

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

791

1.10

0.37

1.7

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

355

1.16

0.37

1.1

1.25

1.36

u/ml

0.08

178

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

272

1.18

0.36

1.8

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

470

0.87

0.35

1.7

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

117

1082

1.08

0.35

2.9

3.5

33.31

64.75

mg/l

1.55

879

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.62

0.35

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.62

0.35

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.62

0.35

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.62

0.35

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

363

0.85

0.35

1.9

1.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

117

1.28

0.35

1.9

1.8

50.82

57.54

ug/l

0.21

112

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

215

2036

1.06

0.34

6.9

8.5

1.26

1.36

0.82

215

2024

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

218

1.19

0.34

1.3

1.5

6.81

6.98

u/l

0.02

181

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.32

0.33

1.6

1.5

—

(3016228) CD19 cells/100 cells in Blood

127

1.26

0.33

1.6

1.8

7.00

8.64

0.42

121

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

855

1.09

0.33

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

209

1981

1.06

0.33

1.2

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

275

1.17

0.32

1.1

3.25

2.89

u/ml

0.11

105

(3017569) Oxygen content in Arterial blood

164

1.22

0.32

2.2

2.3

—

(3020491) Glucose [Moles/volume] in Blood

230

1.18

0.31

1.7

2.0

6.79

6.78

mmol/l

0.00

149

(4281824) Cell count and differential, peritoneal fluid

379

0.87

0.30

1.0

1.2

—

(3033799) Differential panel - Peritoneal fluid

0.71

0.30

2.6

2.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

240

0.83

0.30

1.4

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

116

1082

1.07

0.30

3.0

3.5

44.87

109.73

mg/l

0.66

880

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

268

1.16

0.30

1.1

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.33

0.30

1.4

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

106

0.75

0.29

1.8

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

364

1.13

0.28

1.6

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

526

1.10

0.28

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

526

1.10

0.28

1.6

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

173

0.81

0.28

2.4

2.7

39.57

42.74

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

700

0.91

0.28

3.7

3.4

24.71

28.30

mg/l

0.32

430

(3023199) Leukocytes [#/volume] in Pleural fluid

407

0.88

0.28

1.4

1.5

3240.19

1807.41

e6/l

0.67

296

(3015183) Erythrocyte sedimentation rate

139

0.79

0.26

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

236

0.85

0.26

2.3

1.5

3.31

4.15

ug/l

0.25

200

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.70

0.26

3.0

2.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

0.70

0.26

2.2

1.5

28.70

25.46

g/l

—

(3000012) Reticulocyte production index

453

1.11

0.25

2.8

2.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

446

0.90

0.25

1.2

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

288

0.87

0.25

1.1

1.2

—

(40768441) Liver Pathology biopsy report

224

0.85

0.25

1.1

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

112

1053

1.07

0.25

3.0

3.4

2.88

1.43

ratio

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

445

0.90

0.25

1.2

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

321

1.12

0.24

5.3

3.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.28

0.24

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

444

0.90

0.24

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

444

0.90

0.24

1.2

1.4

—

(3017704) Immunofixation for Urine

189

1.16

0.24

1.8

1.6

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.71

0.24

1.3

1.4

15.02

30.28

nmol/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

724

0.92

0.24

3.3

0.91

0.81

nmol/l

0.52

558

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

270

2606

1.04

0.23

3.4

2.6

63.26

64.01

ml/min/173m2

0.11

108

1078

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

370

1.11

0.23

1.7

1.6

—

(3014891) Appearance of Pleural fluid

1.32

0.23

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

136

0.81

0.23

1.5

2.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

563

1.08

0.22

1.2

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

200

0.85

0.22

2.0

1.6

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

304

1.12

0.22

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

587

0.92

0.22

1.1

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

420

1.10

0.21

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

199

0.85

0.21

2.0

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

107

1.22

0.21

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.19

0.21

2.6

3.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.0

—

406.30

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

8.3

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3003694) ABO and Rh group [Type] in Blood

849

8351

1.02

0.21

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

1.63

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

3.5

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

230

0.87

0.21

1.1

1.0

39.87

45.37

ng/l

0.42

145

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.38

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

134

0.82

0.20

1.1

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

1.25

0.20

1.2

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.20

0.0

2.2

—

(21494434) Karyotype in Bone marrow

292

0.89

0.20

1.1

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.20

0.19

1.0

2.1

22.25

17.14

umol/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

479

0.92

0.19

1.3

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.21

0.19

1.1

1.0

—

(3037756) Immunofixation for Serum or Plasma

716

0.93

0.19

1.5

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

146

1.17

0.19

1.2

1.4

114.48

151.55

pmol/l

0.84

146

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

228

0.88

0.19

1.1

1.0

717.21

708.61

ng/l

0.03

145

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

228

0.88

0.19

1.1

1.0

258.40

319.84

ng/l

1.02

147

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

228

0.88

0.19

1.8

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

301

0.90

0.18

2.3

2.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

164

0.85

0.18

2.4

3.4

—

(3000034) Microalbumin [Mass/volume] in Urine

290

0.90

0.18

3.4

3.0

46.69

33.92

mg/l

0.17

213

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.21

0.18

1.7

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

388

3791

1.03

0.18

1.4

1.6

—

(3002619) Bacteria identified in Specimen by Culture

1.15

0.17

1.3

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

142

0.84

0.17

1.7

3.41

6.45

nmol/l

—

118

(40768795) Lymph node Pathology biopsy report

339

1.09

0.17

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.11

0.17

1.9

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.76

0.17

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

134

1395

0.96

0.17

1.5

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

267

0.90

0.16

1.0

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

196

1.12

0.16

1.2

1.1

18.65

19.55

u/l

0.05

167

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

298

0.91

0.16

1.4

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.13

0.16

7.1

7.5

—

(40757373) Influenza virus identified in Isolate

1.11

0.16

1.1

1.4

—

(3025130) Human papilloma virus identified in Specimen

401

0.92

0.16

1.4

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

604

1.06

0.15

3.0

5.1

292.14

576.66

iu/ml

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

224

0.89

0.15

1.2

1.5

0.90

0.96

g/l

0.82

224

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

159

1.13

0.15

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.11

0.15

1.8

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

171

0.88

0.14

1.7

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

171

0.88

0.14

1.7

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.80

0.14

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

583

0.94

0.14

1.5

1.4

—

(40768806) Pleura Pathology biopsy report

357

0.92

0.14

1.4

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

353

1.08

0.14

1.3

7.45

7.47

mmol/l

0.01

306

(3051611) Lipemic interference index of Serum or Plasma

353

1.08

0.14

4.1

3.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

773

1.05

0.14

1.8

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

212

0.90

0.14

1.8

1.9

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

228

1.10

0.13

1.3

1.5

12.00

13.34

u/l

0.64

219

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

148

0.88

0.12

1.0

1.1

—

(3035880) pH of Pleural fluid

200

0.90

0.12

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

114

1.14

0.11

1.4

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.16

0.11

3.1

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.16

0.11

3.1

2.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

298

1.07

0.11

1.5

1.4

29.37

31.52

0.13

179

(3051651) Icteric interference index of Serum or Plasma

192

1.09

0.10

3.9

3.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

167

0.90

0.10

1.1

1.3

—

(3012441) Differential panel - Pleural fluid

341

0.94

0.10

1.3

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.11

0.09

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

207

0.92

0.09

1.2

1.1

—

(3011648) Oxygen content in Venous blood

242

1.07

0.09

2.2

1.8

10.80

10.96

0.06

242

(40765096) Chromosome analysis panel by Banding

114

0.88

0.09

1.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

818

0.97

0.09

3.5

3.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.04

0.09

1.0

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

126

1228

1.03

0.09

2.1

3.4

140.19

3606.93

u/ml

0.89

102

1033

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

817

0.97

0.09

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.11

0.09

1.0

—

(3024263) Appearance of Synovial fluid

175

0.91

0.08

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

471

0.95

0.08

1.4

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.83

0.08

1.0

2.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.79

0.08

7.4

7.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

236

0.93

0.08

1.3

15.68

11.72

u/l

0.43

218

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.83

0.07

1.1

—

(3034426) Prothrombin time (PT)

0.86

0.06

1.5

1.3

—

(3036603) Volume of Urine

226

1.06

0.06

1.6

1.4

1956.29

1858.47

0.25

220

(4035726) Immunohistochemistry procedure

296

2995

0.99

0.06

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

356

0.95

0.06

1.4

1.5

0.33

0.31

nmol/l

0.08

271

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

149

1511

0.99

0.04

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

170

1.06

0.04

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

180

0.94

0.04

1.1

1.3

1.54

1.60

g/l

0.33

180

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

513

0.97

0.04

1.3

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

119

0.92

0.04

1.3

—

0.24

g/l

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

452

0.97

0.03

1.5

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

230

2282

1.01

0.03

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

171

1.05

0.03

1.8

2.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

108

0.93

0.03

1.2

1.5

8.02

2.89

—

(3035320) C reactive protein [Mass/volume] in Body fluid

229

0.96

0.02

5.5

2.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

440

1.02

0.02

3.8

6.7

12.74

12.24

mg/l

0.24

407

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

451

1.02

0.02

1.7

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

123

1.06

0.01

2.4

229.57

131.49

umol/l

—

(3020891) Body temperature

135

1340

1.01

0.01

4.6

4.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

297

0.98

0.01

1.3

1.5

—

(40768793) Breast Pathology biopsy report

827

0.99

0.01

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

116

0.95

0.00

1.2

1.1

80.57

185.34

iu/ml

2.59

116

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

112

1114

1.01

0.00

3.1

3.0

0.42

0.35

u/ml

1.09

641

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

112

0.98

0.00

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

118

1.02

0.00

1.2

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.05

0.00

1.1

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

798

1.00

0.00

1.1

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

395

0.99

0.00

1.1

1.33

1.53

g/l

5.43

355

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.01

0.00

2.1

2.3

189.90

181.80

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

111

0.99

0.00

1.2

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

106

1.04

0.00

1.3

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

276

1.01

0.00

1.4

1.9

3.87

4.37

mg/l

0.22

266

(3050129) First trimester maternal screen panel - Serum or Plasma

534

0.99

0.00

1.5

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

493

0.99

0.00

1.1

1.4

136.69

121.08

u/ml

0.20

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.00

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

8.0

—

74.80

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.4

—

153.86

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.4

—

4.20

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.85

-0.00

1.4

1.8

—

73.67

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.1

—

1.34

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.91

-0.00

1.3

1.5

18.02

23.27

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.86

-0.00

1.8

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

0.93

-0.00

1.0

1.2

—

75.31

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

0.93

-0.00

1.0

1.2

—

68.13

—

(3022689) Creatine [Moles/volume] in Urine

0.94

-0.00

1.9

1.5

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

1.30

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

2.08

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.02

-0.00

7.4

7.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_PERIPHVERTIGO and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_PERIPHVERTIGO	0.894 [0.82, 0.97]	0.011
Birth year	0.99 [0.98, 1.0]	0.021

During the follow-up period (1.1.1998 — 31.12.2019), 2271 out of 12753 females with H8_PERIPHVERTIGO died.

Males

Parameter	HR [95% CI]	p-value
H8_PERIPHVERTIGO	0.862 [0.78, 0.95]	0.003
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1428 out of 7125 males with H8_PERIPHVERTIGO died.

Mortality risk

Mortality risk for people of age

years, who have H8_PERIPHVERTIGO.

N-year risk	Females	Males
1	0.056%	0.167%
5	0.442%	1.004%
10	1.156%	2.399%
15	2.051%	4.41%
20	3.659%	7.397%

Relationships between endpoints

↥

Index endpoint: H8_PERIPHVERTIGO – Other peripheral vertigo

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other peripheral vertigo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints